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We developed a carbon nanotube biosensor platform that was deployed at the National 
Cancer Institute and successfully detected the HER2 oncogene in real cancer cells at 
clinically relevant levels. HER2 is a receptor protein that resides on the surface of certain 
cancer cells and is associated with higher aggressiveness in breast cancers. 
Overabundance of HER2 at the chromosomal, cell surface, and intermediate gene 
expression levels can all indicate a dangerous HER2 status.  
At the present, testing for HER2 status requires labor-intensive laboratory 
procedures using expensive reagents. Cost remains the major barrier to widespread 
screening. We propose an integrated electronic testing platform based on direct label-free 
gene detection. The system would integrate the various labor-intensive processes that are 
usually performed by skilled laboratory technicians. The heart of the system is an array of 
carbon nanotube field-effect transistors that can detect unlabelled nucleic acids via their 
intrinsic electric charges.  
  
We developed a scalable fabrication technique for carbon nanotube biosensor 
arrays, hardware and software for data acquisition and analysis, theoretical models for 
detection mechanism, and protocols for immobilization of peptide nucleic acid probes 
and hybridization of nucleic acids extracted from cells. We demonstrated detection of 
HER2 from real cell lines which express cancer genes, thereby lowering the 
technological barrier towards commercialization of a low-cost gene expression biosensor. 
The system is suitable for lab-on-a-chip integration, which could bring rapid, low-cost 
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Chapter 1: Introduction 
This dissertation describes the work I have done during my PhD studies on the 
development of carbon nanotube transistor arrays for the label-free detection of the HER2 
breast cancer gene. Each year in the United States, nearly 200,000 women are diagnosed 
with breast cancer and 40,000 will die from it. The “War on Cancer” in 1971 initiated a 
search for new cancer diagnostics, therapies, preventative measures, and early detection. 
Yet today, cost remains the major barrier to widespread screening.  
We believe that an integrated electronic testing platform based on direct label-free 
gene detection may be the answer to reducing cost. The system would integrate the 
various labor-intensive processes that are usually performed by a skilled technician in a 
laboratory. The heart of the system would be an array of transistors that can detect 
unlabelled nucleic acids via their intrinsic electric charges. We probed for the HER2 
breast cancer gene as a model biomarker on which to prove the detection system. HER2 
status has already been shown to be effective in determining if a patient will respond to 
the drug Herceptin®, which blocks HER2 from taking disastrous effect.  
We embarked on an engineering project to provide a system to be used by 
molecular biologists at the National Cancer Institute to determine the HER2 status of 
breast cancer cell lines. We constructed three dependable experimental platforms that 
provided results repeatedly, an improvement compared to our previous prototype design. 
My colleague Herman Pandana and I began this research completely from scratch, with 
no existing fabrication process and no laboratory experience in molecular biology. We 
discovered that the original goals of the endeavor were far more than one or even two 




In the initial phase of the project, we made the following contributions: 
• Demonstrated a new approach of making carbon nanotube field-effect transistors 
(CNTFETs) with an oxide surface intended for bio-sensing applications, 
• Fabricated and implemented reproducible CNTFETs having intrinsic ambipolar 
transport characteristics, 
• Developed protocols for attachment of synthetic DNA probes onto the CNTFETs, 
• Demonstrated detection of specific synthetic DNA genes in the range of 10 – 
100 nM using CNTFETs. 
 
Using this initial work as a foundation, and with the help of a number of graduate 
students and faculty, I was able to make a number of contributions: 
• Developed scalable fabrication technique for carbon nanotube biosensor arrays, 
• Developed hardware and software for data acquisition and analysis, 
• Developed theoretical models for detection mechanism, 
• Developed protocols for immobilization of peptide nucleic acid probes and 
hybridization of nucleic acids extracted from cells, 
• Demonstrated proof-of-concept with synthetic DNA targets,  
• Demonstrated selectivity, sensitivity, and system reliability,  
• Demonstrated biological validation of technique, 




In summary, it is very gratifying to see the project come to fruition: we were able 
to use our system to discriminate between HER2 positive and negative cell lines. My 
project involved physics, chemistry, device fabrication, biology, computer hardware and 
software and theoretical modeling. I have integrated these diverse fields, and 
subsequently lowered the technological barrier towards commercialization of a rapid, 
low-cost nucleic acid detection system that will be suitable for lab-on-a-chip integration. 
My hope is for my work to have a positive impact on patients’ lives. 
The organization of this dissertation is as follows: We begin with Chapter 2 by 
introducing the carbon nanotube (CNT) and the fabrication process of CNT field-effect 
transistors. We also present experimental results focusing on biosensor chip production. 
In Chapter 3, we will review molecular biology and relevant assays in breast cancer 
detection. Chapter 4 describes the basic principles of electrochemistry and their 
application to charge detection via the CNTFET. Our experiments at the National Cancer 
Institute to detect HER2 from cancer cells are detailed in Chapter 5. Finally, Chapter 6 
outlines proposed items for future work. 
This dissertation attempts to provide all the details necessary for someone to 
reconstruct the system and reproduce the results. Our ultimate motivation is to create 
enough momentum such that investors would be willing to fund a continuation, if not 




Chapter 2: Carbon Nanotubes, Biosensor Fabrication, & 
Electrical Testing 
2.1 Chapter Purpose 
The purpose of this chapter is to impress upon the reader that a large number of 
CNTFET biosensors were produced from a custom design and went through a 
comprehensive testing process. We provide the reader with a basic atomic and electronic 
structure of carbon nanotubes and illustrate in detail how we fabricate biosensors based 
on nanotube transistors. We review the physics of carbon nanotubes to explain their 
intrinsically high mobility, which allows for high-sensitivity transistors. In sensing 
applications, extraordinarily high sensitivity of CNTs unfortunately comes with poor 
selectivity. By coating the CNTs with oxide, we purposefully compromise on sensitivity 
to bring improvements in selectivity and reliability.  
We designed and fabricated arrays of metal-gated transistor arrays using standard 
lithographic techniques and carbon nanotube “mats”. Over 200 biosensors were 
fabricated and samples were tested using an infrastructure of custom instrumentation and 
software. We first review performance at transistor level measurements, then present 
statistical results showing improvements in the quality of production of CNTFET arrays. 




2.2 Principles of Carbon Nanotubes 
In 1991, S. Iijima reported the discovery of a new form of carbon: graphene tubes 
ranging from 4 to 30 nm in diameter.1 These carbon nanotubes (CNTs) exhibit a range of 
electronic properties, ranging from metallic to semiconducting, that depend on their 
diameter and chirality (wrapping angle). 
2.2.1 Atomic & Electronic Structure 
A carbon nanotube (CNT) can be modeled as a cylinder constructed by slicing a 
strip out of a sheet of graphene and joining the long sides together (Figure 1). As a 
consequence of quantum mechanics, the atomic and electronic structure of the resulting 
CNT significantly depends on the orientation of tube axis (T) with respect to the 
hexagonal graphene lattice, as well as the diameter of the tube.  
The chirality of the tube is described by the wrapping vector C, which is 
orthogonal to the tube axis and defines the relative location of two equivalent locations in 
the lattice. The chirality of the tube is specified by a pair of integers (n, m), such that 
C = na1+ma2, where a1 and a2 are the unit vectors of graphene. The diameter of the tube 
is d = |C|/π. If n = m, the chirality is called “armchair” and the wrapping angle is φ = 0°. 
If m = 0, the chirality is called “zigzag” (the atoms along C appear to zigzag), and φ = 
30°. Otherwise, the CNT is simply “chiral”, where 0 < φ < 30°. The wrapping angle can 
also be specified relative to the zigzag direction by θ, where φ = 30° − θ. 
Figure 1 shows an atomically resolved scanning tunneling microscope (STM) 
image of a chiral nanotube. The STM is able to resolve atomic-scale features by 
maintaining a conductive tip within quantum tunneling distances of a surface.2 For this 
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single-walled carbon nanotube, (m, n) = (11, 7), the chiral angle is φ = 7° and the 
diameter is d = 1.3 nm. 
The electronic structure3,4 of the CNT can be either metallic or semiconducting 
depending on tube diameter and wrapping angle due to periodic boundary conditions: 
C∙k = 2πq, where k is the wavevector, and q is an integer. Only a limited set of allowed 
 
Figure 1. Atomic and electronic structure of a carbon nanotube. (left) Atomic lattice structure of 
carbon nanotube based on a graphene sheet. The unit vectors of graphene are a1 and a2. The 
chirality is denoted by the wrapping vector C, which is orthogonal to the tube axis T. The 
chirality is called “armchair” when the wrapping angle is φ = 0°. The solid vector H is 
perpendicular to the armchair direction and specifies the direction of nearest-neighbor hexagon 
rows indicated by the black dots. (right) Scanning tunneling microscopy (STM) image of a 
carbon nanotube with (m, n) = (11, 7), chiral angle φ = 7° and diameter d = 1.3 nm. Source: 
Wildöer et al.3 
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wavevectors can be substituted into the energy dispersion relation for a graphene sheet. q 
labels the 1-D modes. Slight changes in these parameters determine whether a tube is 
metallic or semiconducting. 
If 2n+m = 3q (where q is an integer), then the nanotube is metallic, otherwise the 
nanotube is semiconducting with an energy bandgap of Eg = 6aCC/d, where aCC is the 
carbon-carbon nearest neighbor distance (142 pm). 
All armchair tubes (n = m, or φ = 0°) are metallic. For chiral (0° < φ < 30°) and 
zigzag (φ = 30°) tubes, the following applies. If n – m = 3l, where l is an integer, the tube 
is metallic. Otherwise, it is semiconducting with an energy bandgap of Eg ~ 0.5 eV. 
Given a random distribution of chiralities, 1/3 of nanotubes are metallic, while the 
remaining 2/3 are semiconducting.  
2.2.2 High Mobility 
The first carbon nanotube field-effect transistor (CNTFET) was reported in 1998 
by Tans et al.5 The basic device consists of source and drain wires contacting a single-
walled carbon nanotube laying on a heavily doped silicon substrate capped by a thermal 
oxide (Figure 2). The substrate was used as a common “back-gate” for all the CNTFETs 
residing on it. Application of a voltage to the gate electrode can switch the nanotube from 
a conducting to an insulating state. As shown in Figure 3, the operational characteristics 
of a CNTFET can be qualitatively described by the semiclassical band-bending models 





Figure 2. Schematic cross section of a basic CNTFET device. A single- or multi-walled nanotube 
bridges the gap between the source (S) and drain (D) electrodes. The doped silicon (Si) substrate 
is used as back gate and is capped with silicon oxide (SiO2). The drain current ID is monitored 
while the drain-source voltage VDS is applied across the channel. The back-gate current IB is 
monitored while the back-source voltage VBS is applied to the substrate. 
 
Figure 3. (left) Band diagram of the CNTFET. A CNT with a gap of ~0.6 eV is connected to 
leads with Fermi energy EF by tunneling contacts, indicated by black vertical bars. At points A 
and C, the valence-band edge is pinned to the Fermi energy of the leads. Due to a difference in 
work function between the CNT and electrodes, the bands bend toward lower energy between 
the electrodes (B). For positive Vgate the bands bend more strongly, leading to an insulating state. 
For negative Vgate the bands flatten, leading to a conducting state. (right) The drain-source bias 











Also in 1998, Martel et al.6 analyzed the performance of CNTFETs based on 
individual single- and multi-wall CNTs. Figure 4 contains the output characteristics and 
transfer characteristics of a device consisting of one single-walled CNT (diameter 
1.6 nm). The output characteristic reveals essentially ohmic behavior, like a resistor 
whose value is controlled by the gate voltage. The conductance of the device increases 
with decreasing gate voltage, like a p-channel MOSFET. The p-channel behavior is 
further affirmed by the transfer characteristic, which shows increases of the drain current 
as the gate voltage moves from positive to negative. Both the output and transfer 
characteristics imply that the transport through the CNTFET is dominated by holes.  
Dürkop et al.7 studied CNTFETs with channel lengths exceeding 300 µm and 
found that carrier transport is diffusive and dominated by channel resistance. They 
demonstrated extremely high mobilities on the order of 10 m2/V∙s, which is about 200 
times that of a typical silicon MOSFET.8 Such high mobilities even at such long channel 
lengths are a consequence of the quantum mechanical behavior of charge carriers within 
 
Figure 4. Output and transfer characteristics of a CNTFET. (a) Output characteristic (ID–VSD) 
curves measured for VG = –6, 0, 1, 2, 3, 4, 5, and 6 V, showing ohmic, p-channel behavior. (b) 
Transfer characteristic (ID–VG) curves for VSD = 10–100 mV in steps of 10 mV, showing p-
channel operation. The inset shows that the gate modulates the conductance by 5 orders of 
magnitude. (VSD = 10 mV). Source: Martel et al.6 
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the one dimensional (1D) physical structure of the nanotube, and suggest the application 
of carbon nanotubes in chemical/biochemical sensors. 
2.2.3 Proposed Use in Biosensors 
We propose a CNTFET design based on carbon nanotubes encapsulated in a 
protective top oxide layer (Figure 5). We choose to use CNTs for their high intrinsic 
mobility, nanometer-scale geometry, and uncomplicated fabrication requirements. 
Because a CNT is cylindrical, the spatial confinement focuses the electric field in the 
vicinity of the CNT and thus creates larger effects for any given quantity of gate charge. 
Both the high mobility and cylindrical geometry suggest high charge sensitivity. In 
addition, transistor fabrication using CNTs is far less complicated than in CMOS because 
it does not require deliberate doping of the channel and the contacts. It is also less 
restrictive on the choice of starting substrate. Dense, random networks of CNTs (“mats”) 
can be grown “in-house” on silicon, silicon oxide and other metal-oxides, as well organic 
polymers though nanoimprinting.9  
The feasibility of using transistors based on CNT mats for detection of unlabelled 
DNA was successfully demonstrated by Star et al.13 and others,14 who exploit the fact 
that single-walled CNTs are more sensitive to DNA charge due to their high surface-to-
volume ratio. Since all atoms of the device are surface atoms, the surface to volume ratio 
 









is extremely high so that the effect on a single atom on the surface has far greater 
influence on the overall transduction of the CNT. Unfortunately, this sensitivity is very 
non-specific. For example, Kong et al.10 and Collins et al.11 demonstrated that CNTs are 
extremely sensitive to adsorbed gases such as oxygen, NO2 and NH3. Collins et al.12 
suggested that surface fluctuations are the origin of excess drift (1/f noise) in CNTFETs. 
Furthermore, designs with exposed CNTs, while extremely sensitive, can suffer from 
unacceptable levels of false positive readings and very rapid aging in the corrosive 
environment of biological buffers.  
Our answer to these concerns is to completely bury the CNTs and source/drain 
contacts under a conformal oxide. This prevents their interaction with contaminants from 
the buffer as well as non-specific interactions with nucleic acids. The channel is thereby 
extremely robust and shows the ambipolar transfer characteristics of high performance 
CNT transistors.  
Furthermore, our design uses probes that are directly immobilized on the gate 
rather than substrate backgate used in the design of Maehashi et al.15 One advantage is 
that the gate voltage used in our case is on order of 1 V as opposed to ~10 V. Such large 
voltages are well above the oxidation potential of the electrolyte and could easily cause 
undesirable signals coming from electrochemical processes unrelated to hybridization 
events. These design points are crucial in the optimal operation of CNT based biosensors.  
2.3 Carbon Nanotube Field-Effect Transistor 
The earliest CNTFETs were simply gated using the substrate, which was silicon 
doped to be conductive. While convenient, this method alone provides no way to 
individually control transistors sharing the same substrate. Top-gates address this need, 
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and commonly take the form of a dedicated microfabricated electrode atop an oxide 
layer. As an extreme example, electrolyte can gate a nanotube around the entire 
circumference and length, without any oxide. We develop a general circuit model for the 
CNTFET based on the MOSFET, and review the basic design considerations specific to 
using CNTs. 
2.3.1 Transistor Circuit Model 
The equations that describe the drain current of a CNTFET are similar to those of 
a conventional MOSFET but are modified to account for the different geometry of CNTs. 
Since we will be fabricating devices from dense CNT mats, we replace the concept of 
channel width W with the number of parallel CNT channels NCNT. We realize that NCNT is 
not well-defined for a channel comprised of a random CNT network. In this case NCNT 
represents the equivalent or effective number of parallel channels. The next task is to 
replace COX, the MOS oxide capacitance per unit area, with the gate capacitance per unit 
length of a CNT, CG. The solution is to replace COXW with NCNT CG, which maintains 
proper dimensions. Also, we recognize that CNTFETs are intrinsically ambipolar,16 but 
will model them as n-channel devices for simplicity. 
The CNTFET operates in three different regimes of operation (deep ohmic, 
ohmic, and saturation) that are distinguished by the voltages applied to the device. For the 
saturation (0 < (VGS−VTH) < VDS) and ohmic (0 < VDS < (VGS−VTH)) regions, the drain 
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where µ is the mobility, CG is the gate capacitance per unit length of the CNT, L is the 
length of the transistor, VGS is the voltage drop from gate to source, VTH is the threshold 
voltage, and VDS is the voltage drop from drain to source.  
In our back-gating experiments, the drain voltage VDS is biased to only 0.1 V, 
whereas magnitude of the gate voltage is usually anywhere from 10 V to 40 V. In this 
“deep ohmic” region (0 < VDS << (VGS−VTH)), the drain current is approximated as: 
 






This linear relationship between the drain current and voltage justifies describing the 
channel under low bias as ohmic. In the output characteristic, the deep ohmic behavior is 
near the origin.  
The output and transfer characteristics of an idealized CNTFET are shown in 
Figure 6. These curves have the exact same shape as those of the ideal nMOSFET, with 
the exception that the ambipolar nature of the CNTFET is depicted by mirroring the 
transfer characteristic across the line (VGS – VTH) = 0. In a similar vein, the output 
characteristic for any given VGS = VGS,k is the same for VGS = −VGS,k (assuming VTH = 0). 
The transconductance (gm ≡ ∂ID/∂VGS) of the CNTFET can be calculated for any 
of the three bias conditions but is easily recognizable as the slope of the transfer 
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characteristic. In practice, we calculate gm by fitting a line to the transfer characteristic in 
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where gds ≡ ∂ID/∂VDS, which is the small signal output conductance. 
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2.3.2 Transistor Design 
The design of the CNTFET-based biomolecular sensor will be similar to that of 
the MOSFET-based ion-sensitive FET (ISFET) used in pH sensors and the like.17 The 
engineer must choose transistor width and length, as well as oxide material and thickness 
within the design requirements of (i) sensitivity, (ii) selectivity and reduction of false 
positives, (iii) device manufacturability, (iv) compatibility with conventional molecular 
biology protocols, (v) signal response calibration and (vi) modeling. In the case of the 
CNTFET, the unit element of width is the tube. The diameters of the tubes are not well-
   
Figure 6. Output and transfer characteristics of a model n-channel CNTFET (NCNT = 1, μ = 
10 m2/V/s, CG = 250 pF/m, L = 500 µm). (left) Output characteristic (ID–VDS) curves for VGS−VTH 
= 0.5–1.75 V in steps of 0.25 V. The dotted curve indicates the boundary between the ohmic 
region VDS < (VGS−VTH) and the saturation region VDS > (VGS−VTH). (right) Transfer characteristic 
(ID–(VGS−VTH)) curves for VDS = 0.05–1.25 V in steps of 0.25 V. The dotted curve indicates the 
extreme of the saturation condition (VGS−VTH) < VDS. The ohmic region is the straight part of 

















































controlled, but are on the order of 1 nm for single-walled nanotubes.18 The overall width 
of the sensor can be increased by connecting tubes in parallel. Since the CNT is of a 1D 
nature, the length of the sensor has little impact on conductance for lengths greater than a 
few microns. In fact, defects and Schottky barrier modulation at the contacts19 may play a 
greater role in sensitivity. Assuming the contacts have already been engineered, the oxide 
thickness is the remaining major design parameter. The choice of oxide thickness will be 
a compromise between a desire of thick oxide to minimize electrolyte current leakage and 
the desire of thin oxide to maximize the gate coupling capacitance. The following 
derivation will show that the cylindrical nature of the CNT reduces the requirement for 
extremely thin oxides. 
A toy model for the nanotube-oxide-gate structure is the standard electrostatic 
textbook situation of a conducting tube (cylinder) in embedded in a dielectric in 
proximity to a conducting plane. We will assume that all three objects are infinite in one 
dimension so that the problem can be solved in only two dimensions. The problem 
reduces to strategically positioning a line of charge a certain distance from the plane that 
satisfies the boundary conditions of the tube and plane. To aid in problem solving, we use 
the method of images; a fictitious image charge of equal and opposite magnitude to the 
first is placed within the plane. The original line charge and its image are an equal 







Figure 7. Cross-section of conducting tube T2 embedded in dielectric (ε) near a conducting 
plane. The negative and positive line charges, –ρ and +ρ, are of equal magnitude and placed 
equidistant from the planar surface (vertical line). The negative charge −ρ is a distance d2n to the 
right of the tube axis. The positive image charge +ρ is located a distance d2p to the right of the 
tube axis. Axes of the tubes and line charges all lie on the horizontal axis shown in dotted line. 
 
 
Figure 8. Cross-section of electrostatic model updated to include an equipotential image tube T1 
with its axis located distance D21 to the right of the axis of tube T2. The same setup models a 














First, we must find the location of the equipotential cylinder around one of the 
two line charges. As shown in Figure 7, a negative line charge −ρ is located a distance d2n 
to the right of the axis of the equipotential tube T2 of radius r, such that d2n < r. Then a 
positive image charge +ρ is placed at a distance d2p to the right of the tube axis. From 
geometrical arguments,20 it turns out that d2n = r2/d2p makes the tube surface (2) 
equipotential.  
Next, we bring in a fictitious image tube T1 and place its axis at d2n to the right of 
the image charge +ρ, as shown in Figure 8. By symmetry, both tubes T1 and T2 are 
equipotentials, and so is the surface of the conducting plane. The distance between the 
 
Figure 9. Calculated electric field intensity and potential contour lines (dotted) of a 2 nm 
diameter tube (r = 1 nm) at 1 V potential, embedded in dielectric and located 5 nm from a 





























two tube axes is D21 = d2p + d2n = d2p + r2/d2p. Given the radius of the tube and the 
distance of the tube from the conducting plane, one solves a quadratic equation  to 
determine the positions of the tubes and corresponding line charges. 
The electric field intensity and electric potential in the dielectric is calculated by 
the superposition of the fields and potentials from the two line charges. We plot the field 
and potential modeling a 2 nm diameter CNT embedded in dielectric at a distance of 
5 nm (D21 = 10 nm) from a conducting plane in Figure 9.  
To calculate the capacitance of the tube to the conducting surface, we need to find 
the voltage of tube T1 with respect to the conducting plane. Let x denote horizontal 
position, and let the vertical line of symmetry be the plane where x = 0. Taking the 








where ε is the dielectric permittivity. By symmetry, the voltage of tube T2 is V2 = −V1. 
The capacitance per unit length between the tube and the conducting plane is given by the 






C πε  (7) 
 
where h = D21/2 is the height of the tube axis from the conducting plane. Using 
the identity arcosh(x) = ln(x+(x2−1)1/2), we see that for h/r >> 1, we can approximate the 
denominator as arcosh(h/r) ≈ ln(2h/r). Since ln(x) is a slow function when x >> 1, it 
follows that the capacitance varies little when h/r > ~6.  
Figure 10 plots the gate capacitance as a function of height for a 2 nm diameter 
tube (r = 1 nm) embedded in aluminum oxide (Al2O3). This model is applicable to the 
 20 
 
top-gated CNTFET of Figure 5. We see that the capacitance is indeed a slow function of 
height when h > 6 nm.  
Note that we cannot blindly apply (7) to actual CNTFETs because the dielectric 
above the nanotube is often different than the dielectric below it. In a back-gated bare 
CNTFET (Figure 2), the CNT is resting atop silicon oxide but the dielectric medium 
above it is air. Therefore (7) overestimates the electrostatic gate capacitance. For 
example, the capacitance of a nanotube of diameter 3.9 nm (radius r = 1.95 nm) 
embedded in SiO2 (εox = 3.7 ε0) at a height h = 500 nm above a conducting plane is CG = 
33 pF/m. All else equal, an electrostatic simulation7 for a CNT sitting atop a 500 nm thick 
SiO2 yields a lower back-gate capacitance of CG = 19 pF/m. 
 
Figure 10. Capacitance per unit length of a 2 nm diameter tube (r = 1 nm) embedded in 
aluminum oxide (ε = 10ε0) as a function of height h from conducting plane. The capacitance 
varies little at sufficient distances (h > 6r).  



















For use as a charge sensor, the top-gate capacitance (from CNT to electrolyte) 
should be much higher than the back-gate capacitance (from CNT to silicon substrate). 
According to Figure 10, the top-gate CG is about 100 pF/m when the oxide thickness h = 
50 nm, which is a practical oxide thickness. Thus, we can expect the top-gate to be only 
five times as effective as the back-gate. We might be tempted to reduce the top-gate 
oxide thickness to achieve higher capacitance. Unfortunately, Figure 10 shows that major 
gains in CG would only be achieved when oxide is less than 6 nm thick. From experience, 
we found that even 25 nm oxide yielded many failures due to pinholes and defects. These 
 
Figure 11. Overlay of all masks for chip fabrication, plus cross section of tubular reservoir. 
Array of 104 CNTFETs is vertically aligned along red middle strip. Their drain leads connect to 
bonding pads, the red squares around perimeter. Design is separated into top and bottom halves, 
where each half contains 50 accessible transistors and one T-shaped common source electrode. 
An on-chip gate electrode running horizontally across the middle is not currently used. Three 









problems are amplified because the oxide does not grow directly on CNTs. Ultimately, 
the judicious choice of a high-κ dielectric in combination with an appropriate top-gate 
oxide thickness provides the optimal compromise between top-gate coupling and 
adequate protection.  
2.3.3 CNTFET Array Layout 
The fabrication of the first CNTFETs involved growing randomly oriented CNTs, 
locating suitable CNTs via scanning electron microscopy, and using the SEM to expose a 
pattern on a resist designed for electron beam lithography. Using this time-consuming 
process, Dürkop et al.7 made CNTFETs with single CNTs spanning channel lengths 
exceeding 300 µm. The fact that transistors of these lengths were functional paved the 
way for the massively parallel fabrication of similar devices using standard 
photolithography. 
Rather than using single-CNT channels, we developed arrays of transistors based 
on high-density CNT networks (“mats”) between the source and drain. The mask layout 
for fabricating an array of CNTFETs using standard photolithography is shown in Figure 
11. A spider-like formation of numerous leads connects a central array of transistors to 
bonding pads around the square perimeter. The layout contains two sub-arrays containing 
50 individually accessible transistors which share a T-shaped common source electrode. 
The mask will be shown in closer detail in the fabrication section.  
As shown in Figure 12, the design uses a plastic tube to contain the liquid bathing 
a large number of transistors. Adding more transistors allows for increased data 
throughput and the possibility of multiple molecular probes per chip. The liquid 
containment tube provides a stable liquid environment over all the transistors during 
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chemical exposure protocols, as well as during the top-gating experiments. In this design, 
the bonding pads were placed on a perimeter large enough to accommodate attachment of 
a plastic tube up to 5 mm outer diameter, which we refer to as the “reservoir”. Larger 
liquid volume means evaporation does not shorten the duration of experiment.  
2.4 Biosensor Fabrication Process 
The biosensor fabrication process starts with a clean silicon wafer and produces a 
finished product comprised of a functional CNTFET array. Fingertip-sized chips are 
diced from a wafer and dusted with a fine layer of pure iron (Fe). The iron serves as the 
catalyst for the subsequent growth of carbon nanotubes using high temperature chemical 
vapor deposition (CVD). With CNTs covering nearly the entire chip, the first step in the 
microfabrication process removes large patches of CNTs to reduce the coverage to only 
the active transistor areas. Next, contacts are made from the nanotubes to the perimeter 
bonding pads, oxide is grown over the nanotubes, and the bonding pads are exposed and 
 
Figure 12. Finished biosensor chip mounted onto leadless chip carrier (LCC), wire bonded, and 






built up. The final step is the fabrication of the metal gates, after which the biosensor is 
ready for attachment to a chip carrier, wirebonding, and the attachment of the tubular 
reservoir. A detailed discussion of each step is presented below. 
2.4.1 Wafer Dicing 
The starting material for fabrication is a 4” (100 mm) wafer of silicon capped with 
500 nm of thermal oxide. The substrate (Silicon Quest International) is 525 µm thick and 
highly doped p-type with boron (B) to a resistivity of 1 to 10 Ω∙cm. The wafer is mounted 
onto an adhesive tape to support the numerous individual chips after dicing. 
Figure 13 shows a wafer diced into about fifty 10 mm x 12 mm chips on a Disco 
DAD 321 Automatic Dicing Saw at the Laboratory for Physical Sciences (LPS). This 
particular size was required due to the relatively small diameter of the quartz tube furnace 
used to grow the nanotubes. Each chip is then individually cleaned with streams of 
 
Figure 13. Photograph of diced 100 mm silicon wafer. The rectangular chips (10 mm by 12 mm) 
still have a protective polymer coating and are attached to the dicing tape. Each wafer yields 
about 50 useable chips. 
 25 
 
acetone, methanol, isopropanol, and deionized water (DI). The final cleaning is done by 
oxygen plasma ashing to remove organic residues. Then identification numbers are 
marked on the chips using a diamond tip scribe. 
2.4.2 UHV Iron Deposition 
High-purity iron (Fe) nanoparticles for the catalyzed nucleation of carbon 
nanotubes were deposited onto each chip by an electron beam evaporator in an ultra-
high-vacuum (UHV) system at the LPS. The deposition of one monolayer of iron is 
typically performed at an absolute pressure of around 500 nPa and is complete within 
about 1 minute. At this pressure, the formation of one monolayer of background 
 
Figure 14. Iron deposition using the ultra-high vacuum electron beam evaporator in the 











contaminants is more than 10 minutes, allowing for the deposition of a high purity iron 
film.  
The UHV system, shown in Figure 14, is isolated from the ambient via a fast-
entry load lock which only allows a handful of chips to be processed per cycle. 
Deposition was performed by personnel trained in operation of the complex vacuum 
system and specialized manipulators required for UHV. The iron evaporator itself 
requires a skilled technician to perform proper start-up and operation procedures such as 
manual adjustment of the high-voltage supply to maintain the proper ion flux density. 
2.4.3 CNTCVD 
The CNTs are grown via a high-temperature chemical vapor deposition (CVD) 
 
Figure 15. Schematic of carbon nanotube chemical vapor deposition (CNTCVD). The inlet gases 
include argon for purging, hydrogen for reduction of iron, and methane and ethylene to provide 
carbon for nanotube growth. The temperature of CNT growth is 850 °C. The cooled exhaust 














process in the Fuhrer lab in the Physics Department. This involves loading the iron-
coated chips into a tube furnace and growing the nanotubes at 850 °C for 10 min using a 
mixture of H2, CH4, and C2H4 using the flow rates and following the method described by 
Kim et al.21 As shown in Figure 15, argon (Ar) is manifolded with the three CNT growth 
gases for the purpose of purging the system to avoid hazardous buildup of flammable 
gases. The exhaust is vented to a fume hood. The process steps are as shown in Table 1. 
The following sequence outlines the events happening during the birth of 
nanotubes. During the heating phase, the sub-monolayer iron film reorders into 
nanoparticles given the significant kinetic energy of atoms at 845 °C. During the growth 
phase, the hydrogen gas first reduces the iron islands to elemental iron. Then the metallic 
particles absorb carbon from the flow of hydrocarbon gases until the point of saturation. 
Once a catalyst particle reaches saturation, the carbon nanotube rapidly grows out from it 
Table 1. CNTCVD process steps used at UM Physics. 
1. Flush: Open (CCW) argon (Ar) rotameter to 20 mm (729 sccm), at room 
temperature (RT), for 5 mins. 
2. Purge lines: Close Ar Swagelok (CW). Open rotameters (CCW) of 
hydrogen (H2) 93 mm (1900 sccm), methane (CH4) 23 mm (1240 sccm), 
ethylene (C2H4) 5 mm (18 sccm), RT. Purge for 5 mins. 
3. Heat up: Set Ar flow rate to 20 mm and ramp from RT to 850 °C (about 
45 mins). To reduce overshoot, take smaller steps: 650, 750, 825, 845 °C. 
4. Grow CNTs: Close Ar Swagelok, open H2, CH4, C2H4 Swagelok valves 
and confirm H2 93 mm, CH4 23 mm, C2H4 5 mm. Hold at 845 °C for 
10 mins. Purpose of hydrogen gas is to reduce iron oxide (Fe2O3) islands 
to the elemental state (Fe). 
5. Cool: Turn off H2, CH4, C2H4 Swagelok valves (CW). Immediately turn 
on Ar 20 mm. Set temperature to 30 °C. This usually takes about 200 mins 
but can be accelerated by partially opening the heater module. 
6. Vent: T<200 °C, turn off the main cylinder valves (CW) of H2, CH4, 
C2H4, then Ar. Open the Swageloks (CCW) and rotameters (CCW) to vent 
out the regulators and supply lines. After venting, decrease the regulator 
controls (fully CCW) and close the outlet valves (CW). Close the 
Swageloks (CW) and gently close the rotameters (CW). 
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until stopped by collision or other environmental disturbance. The carbon nanotubes 
generated by this process have been shown to be mostly single-walled and about two-
thirds are semiconducting.22 The density of catalyst particles determines the density of 
the CNT mat. 
Successful growth of CNTs is associated with direct visual observation of a dark 
circle corresponding to the UHV iron deposition spot, as shown in Figure 16a. Since this 
preliminary observation could also be due to a layer of amorphous carbon soot or 
buckyballs, we must use more advanced imaging methods to confirm the success of 
CNTCVD. 
Atomic force microscopy (AFM) is a variant of scanning probe microscopy where 
a sharp tip is rastered over a surface and atomic force interactions are measured or used 
(a) (b)  
Figure 16. (a) Photograph of SiO2/Si chip #382 after CNTCVD taken at proper viewing angle for 
contrast of nanotube film against substrate. The arrows indicate the edges of the dense CNT 
network, corresponding to the boundaries of iron film. (b) Atomic force microscopy (AFM) 3D 
rendering of carbon nanotubes (black) on silicon oxide substrate (purple). The white peaks 
indicate iron nanoparticles or possibly undeveloped carbon buckyballs. One can observe overlap 
of nanotubes in foreground and midground. It is believed that the growth of individual nanotubes 
is very rapid once nucleated on an iron nanoparticle, and growth stops when the sprouting end of 
the tube hits an obstacle. 
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as feedback signal.23 This method was used to image the height topography of the 
nanotubes as shown in Figure 16b, which suggests the CNTs are forming a random 
network. If one traces the path of one tube, it is apparent that it may overlap or be 
overlapped by other tubes, implying the sequential growth of CNTs. Furthermore, the 
junctions between the tubes may have consequences on the mobility and transistor 
behavior of the overall network. 
Scanning electron microscopy (SEM) is a quick, non-contact non-destructive 
method that we routinely used to confirm the growth of dense networks of CNTs. Figure 
17 shows how CNTs grown from our sub-monolayer iron catalyst form a very high-
density randomly ordered network suitable for the large-scale fabrication of transistors. 
For comparison, the CNTs grown from ferric nitrate (FeNO3) catalyst solution24 are very 
sparsely distributed and too short to enable large-scale fabrication. 
 
Figure 17. Scanning electron micrographs (SEM) of CNTs (light) on oxide substrates (dark). The 
contrast of the CNTs against the substrate, as explained by Britlinger et al.25, is due mainly to 
differing electron charging and discharging effects. (left) High-density randomly ordered CNT 
network (“mat”) grown from UHV iron and suitable for mass fabrication of transistors. (right) 
Low-density randomly nucleated islands of CNTs grown from FeNO3 catalyst solution. 
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2.4.4 Microelectronic Fabrication Process 
With carbon nanotubes already covering the silicon oxide substrate, the next steps 
are to build the transistor source and drain contacts using standard cleanroom processing 
techniques. While the microelectronic fabrication process is similar to that of a silicon 
MOSFET, there are some unique considerations when working with CNTs. Since all 
chemical bonds of the graphitic carbon atoms are filled, there are no dangling chemical 
bonds on the CNT as silicon has. A positive consequence is that CNTFETs may 
incorporate a broader choice of oxide material than silicon devices, which are plagued by 
detrimental oxide interfacial states. This same reason is responsible for why CNTs do not 
adhere well to a many materials.  
Since the bonding pads will be ultrasonically wire-bonded to a chip carrier, we 
need excellent adhesion of the bonding pad films to the substrate. Furthermore, we need 
the source and drain metal leads to maintain adhesion to the substrate under varying 
temperatures and moisture levels. To increase adhesion of both the bonding pads and 
metal leads, we re-designed the process to clear out CNTs from the area underneath these 
areas as much as possible.  
We also experienced an adhesion issue when we started to use gold to decrease 
the resistance of the metal leads. This resistance was responsible for increasing the 
apparent threshold voltage of transistors due to significant voltage drop from the 
transistor source to the source bonding pad. The use of gold reduced this effect, but 
caused decreased adhesion with the ALD aluminum oxide. This is the reason for using a 
triple layer (Ti/Au/Ti) for the metal wires. 
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The biosensors were almost entirely fabricated at facilities within the University 
of Maryland, College Park. Most process steps were performed in the cleanroom of the 
Laboratory for Physical Sciences (LPS). The equipment used included the Zuss MJB-3 
Mask Aligner, Plasmatherm 790 reactive-ion etcher (RIE), and CHA industries electron 
beam evaporator. Other process steps were performed in the Department of Physics and 
the FabLab Class 1000 research cleanroom. The details of the microfabrication steps will 
be discussed in the following. 
2.4.4.1 Alignment Marks 
Figure 18 shows the mask for alignments used in subsequent processing steps. 
Upon their entrance into the cleanroom environment, the chips are rinsed with acetone, 
methanol (MeOH), and isopropanol (IPA), and blown dry in nitrogen (N2). Ultrasonic 
cleaning, piranha etch, and other harsh cleaning methods were not used because it would 
remove the CNTs.  
Standard photolithography was used to transfer patterns in a contact mask to a 
photoresist. After the chips were spin-coated with Futurrex NR9-1500PY negative 
photoresist, a pre-exposure bake was done on a 150 °C hotplate for 60 s. Then the pattern 
in the mask was transferred by exposure for 16 s with a 350 nm (i-line) wavelength 
contact aligner. The post-exposure bake is 100 °C on a hotplate for 60 s. Pattern 
development was done by immersion in RD6 for 15 s. The masks shown are clear field 




To ensure good adhesion of the metal film, the chip is exposed to oxygen plasma 
for 20 s to remove CNTs. Then 5 nm of titanium (Ti) was evaporated, followed by lift-off 
in acetone, allowing for direct adhesion of the Ti film on the area colored with red, while 
CNT mats still remain elsewhere. This first metal layer serves as the alignment reference 
for subsequent pattern transfers. 
 
2.4.4.2 Unwanted CNT Removal 
The CNTs in the inactive areas (field) are removed prior to the deposition of any 
metal wires or bonding pads. The CNTs remaining in the active area are in the channel 
gap (under the gate) and a 10 µm overlap with the source and drain leads. Figure 19 
 
Figure 18. (left) Single contact mask containing patterns for entire fabrication process: 
(clockwise quadrants starting from upper right) metal wires, bonding pad etch/deposition, 
alignment marks, and field ash. The rectangular outline containing three small boxes 
representing etched numbers indicates the position of a chip ready for alignment marks. (right) 
Zoomed view of mask for alignment marks (red) and outline indicating proper chip position 
(blue). The alignment marks have 2 mm spacing. 
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shows the mask pattern used for this step. The goal is to remove all CNTs except for 
where the mask is opaque. 
To begin this step, we spin OIR 908-35, a positive photoresist and bake it at 90 °C 
on a hotplate for 60 s. Then the pattern in the mask was transferred by exposure for 13 s 
on the contact aligner. There is no post-exposure bake for this step. Pattern development 
was done by immersion in OPD4262 for 60 s. The positive resist will be developed away 
only in the open areas of the mask. As before, CNT removal is accomplished by exposing 
the chip to oxygen plasma. CNTs remain only in the areas protected by photoresist. The 
end result is a chip with alignment marks and CNTs in the active areas. 
2.4.4.3 Metal Contacts & Leads 
After clearing out unwanted CNTs, we are ready to deposit the metal wires. These 
include the source and drain contacts to the CNTs, as well as wires that lead from the 
CNTFETs proper to the bonding pads. NR9-1500PY coating, pre-bake, exposure, post-




Figure 19. (left) Mask for ashing of CNTs in the field. (right top) Zoomed view of mask showing 
twelve CNTFET active areas. (right bottom) Cartoon illustration of cross-section of remaining 





mask shown in Figure 20. Then the appropriate metal is evaporated and lift-off is 
performed in acetone. At this stage, the transistor is a bare CNTFET; back-gate testing is 
described later in Section 2.5.1.1. 
Based on the literature on annealing CNTFETs,16 the metal layer of our early 
chips was a single layer of titanium (Ti) only 50 nm thick. Given that titanium is 19 times 
less conductive than gold, and the wires from the bonding pads are long and skinny, we 
suffered a series resistance on the order of 10’s of kΩ. Upon realizing that we did not 
need to pursue annealing but needed to decrease the source and drain wire resistance, we 
changed the recipe to 100 nm of gold (Au) on 10 nm of titanium (Ti). This resulted in 
decreasing the wire resistance to about 100 Ω and improved the average 
transconductance from 0.6 µS to 2.5 µS. 
2.4.4.4 Atomic Layer Deposition (ALD)  
As shown in Figure 21, approximately 50 nm of aluminum oxide (Al2O3) is 
deposited via atomic layer deposition (ALD) performed either on campus or at 
 
  
Figure 20. (left) Mask for the source, drain, and corresponding leads of the metal layer. (right) 
Zoomed-in cross-section of two transistors after metal (Au with Ti adhesion layer) for drain 
electrodes (left and right) and common source electrode (middle) are deposited onto substrate 





Cambridge Nanotech, Inc (Boston, MA). The principle of ALD is based on sequential 
pulsing of precursor vapors which individually react with the sample surface to generate 
one layer per pulse. The resultant oxide coating is highly conformal and of quality 
suitable for transistor gates. Other oxides such as thermally evaporated silicon dioxide 
layers were unreliable; pinholes in the insulator lead to cracking and degradation under 
conditions of electrolysis. 
ALD films of aluminum oxide were deposited using alternating doses of 
trimethylaluminum (Al(CH3)3 or TMA) and water (H2O). During the TMA pulse, methyl 
groups are released as the aluminum binds with oxygen from hydroxyl groups on the 
surface. The methane by-product is subsequently pumped out, along with any excess 
TMA. During the water pulse, the water vapor converts methyl groups of the bound TMA 
into fresh hydroxyl groups available for binding during the next TMA pulse. In this 
manner, the oxide film is built layer-by-layer.  
On our sensors, the ALD grows on the silicon oxide substrate; the CNTs do not 
participate in the ALD reactions. Eventually the oxide film grows to envelop the CNTs. 
Ultimately the biosensor will be exposed to a wet buffer electrolyte full of ions. One of 
the most important reasons for choosing Al2O3 is that it is a good barrier against mobile 
alkali ions, which have been the cause of device instabilities in SiO2 films.26 For 
 
Figure 21. Illustration of cross-section of transistor after atomic layer deposition (ALD) of top-
gate oxide. The oxide layer (green) is depicted as unidirectional, but actual ALD films are 




example, potassium, a common component of biological buffers, is mobile in silicon 
oxide.27 Another advantage to using Al2O3 is that its high dielectric constant (high-κ) 
allows for a more sensitive device. 
2.4.4.5 Bonding Pad Oxide Etch & Deposition 
With ALD oxide covering the entire chip surface, the next step is to regain access 
to the bonding pad areas of the metal wire layer. NR9-1500PY photoresist was patterned 
to leave open features corresponding to the bonding pads (red squares) in Figure 22. To 
reduce oxide degradation due to thermal stresses, the pre-exposure bake and post-
exposure bake were done at a reduced temperature of 110 °C for 5 minutes. 
The top oxide covering the bonding pad areas is removed via fluorine-based 
reactive ion etching (40 mTorr, 18 sccm CHF3, 2 sccm O2, 175 W). This recipe normally 
achieves an etch rate of 50 nm SiO2/min. However, since aluminum fluoride is not 
volatile, it only achieves 2.5 nm Al2O3/min; the etching may be dominated more by 
sputtering than chemical reaction. The etch is run for approximately 25 minutes, such that 
openings (windows) have been etched completely down to the underlying gold.  
   
Figure 22. (left) Mask for bonding pads. (right) Cross-section of a CNTFET for which bonding 
pads have been deposited. 
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After etching windows to the bonding pads, the same photoresist serves as a lift-
off mask. Without removing the NR9 resist, 300 nm of gold is deposited via electron-
beam evaporation. This relatively thick layer is needed for strong wire bonds. Liftoff is 
done in acetone as before. 
2.4.4.6 Metal Gates  
The next cleanroom process is to create the CNTFET gates, which also serve as 
surfaces on which to attach probe nucleic acids. The pattern for the gold attachment 
surfaces (GAS) is created using the same photomask used to remove unwanted CNTs 
(Figure 19). NR9-1500PY photoresist is patterned to leave open features corresponding 
to the CNT areas. Any remaining resist residue (“scum”) is removed through exposure to 
oxygen plasma for 15 s. The resist pattern is now ready for the metal deposition and 
subsequent lift-off in acetone.  
Since gold does not adhere well to aluminum oxide, we must first deposit an 
adhesion layer such as chromium (Cr) or titanium (Ti). Early in the development of 
metal-gated transistors, we found that titanium gave us VTH too far negative, and that 
chromium placed the threshold voltages closer to zero. However, as we explain in detail 
 
Figure 23. (left) Cross-section of finished CNTFET including gold attachment surfaces (GAS). 
Mask for field ash (FA) is reused for this step. (right) Microscopic view of six CNTFETs, 
including six gold gates, six drain wires, and one common source wire in middle. 
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in Section 2.5.4.2, we ultimately switched to palladium (Pd) after we started using ALD 
oxide from an external vendor. The current practice is to deposit 7 nm Pd and 100 nm Au 
by e-beam evaporation. As shown in Figure 23, the resulting structure is a floating-gate 
CNTFET; testing is discussed later in Section 2.5.1.2.  
2.4.4.7 Protective Coating 
The final cleanroom process is the application of a protective coating that 
prevents etching of the aluminum oxide surrounding and underneath the metal gates. We 
discovered through side experiments that aluminum oxide, while relatively impervious to 
ion penetration, has the weakness of a slow but significant etch rate in the hybridization 
buffer. Overnight exposures to buffer caused the film to change color and became 
hydrophilic. The color change indicates a reduction in thickness, while the hydrophilic 
nature implies an abundance of fresh surface hydroxyl groups due to etching. 
The mask for this step, shown in Figure 24, is a combination of the patterns for 
the metal gates and the bonding pad windows. First, Microchem PMGI SF8 is spun to a 
thickness of ~600 nm, then baked at 180 °C for 60 s on a hotplate. Next, the film is 
 
Figure 24. (left) Mask for protective coating. (right) Close-up of gate areas over which the 
protective coating has been patterned. The coating remains on the field but has been etched away 
over the metal gates. The coating is patterned such that the openings are smaller than the metal 
gates and bonding pads. 
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thinned to ~150 nm in RD6 developer. After rinsing and drying, NR9-1500PY 
photoresist is spun and patterned to leave open features over the metal gates and bonding 
pads. The exposed PMGI SF8 is removed via oxygen plasma for about 4 minutes. At this 
point the chips are ready for final electrical testing on a probe station using needles to 
make direct connections to the source and drain, and a fine gold wire to contact 
individual gates.  
2.4.5 Wirebonding & Reservoir Attachment 
Upon passing the electrical quality control testing, the chip will be mounted to a 
chip carrier and wire bonded. The chip is mounted to the 68-pin ceramic leadless chip 
carrier (LCC) using room temperature vulcanizing (RTV) silicone sealant. As shown in 
Figure 25, the connections from the LCC to the chip are wirebonded using a West•Bond 
747677E-79 wire bonder at LPS. 
 
  
Figure 25. (left) Photograph of chip after mounting on the LCC068 and wirebonding. (right) 
close-up of wire bonds created by a wedge bonding tool with ultrasonic agitation. The bond 
wires are 25 µm in diameter. 
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Next a liquid containment reservoir is attached using silicone sealant (Figure 11). 
Reservoirs were made from a section of a certified nuclease-free MBP pipette tip cut on 
one side using a hot-knife. Other variations of the reservoir have been used (such as 
sections of thick-walled polypropylene tubing, and thin-walled PCR tubes).  
The biosensor can now be used in molecular biology experiments. Wet 
measurements can be done easily on the automated measurement platform. Liquid-gated 
chip performance is tested before any probe molecules are immobilized. 
2.5 CNTFET Electrical Testing 
Throughout the biosensor fabrication process, we perform a series of 
measurements to confirm the quality of the transistors. This is important because the 
downstream processes and experiments consume time and effort that must be carefully 
spent. The electrical measurements consist of mainly of the transfer characteristics and 
occasionally the output characteristics as measured on a probe station. Here we present 
data on representative transistors and extract parameters such as the transconductance and 
field-effect mobility. Although it is difficult to correlate the mobility of our devices with 
the intrinsic mobility of individual carbon nanotubes in the literature, we extracted a 
value still significantly higher than found in silicon MOSFETs. A more important 
parameter to us is the threshold voltage, which we characterize for entire CNTFET arrays 
during fabrication to ensure viability of the finished chip in the final application as a 




2.5.1 Transfer Characteristics 
2.5.1.1 Bare CNTFET, Back-Gated 
After a few lithography steps, the chip is mid-way to fabrication completion and 
is tested to confirm proper transistor operation. At this point, the carbon nanotube active 
areas have been defined and the non-active areas are cleared free of CNTs. The source 
and drain contacts, along with the wires leading to the bonding pads, have also been 
formed. Thus, we are able to measure “back-gate” characteristics using the basic setup 
shown in Figure 26 to scan the back-gate voltage VBS while maintaining the drain bias 
VDS = 0.1 V. While ohmic contact to the silicon substrate is not a trivial matter, we use a 
salt solution to conduct the small charging currents required.  
The highly consistent transfer characteristics in Figure 26 indicate that the 
intrinsic device parameters such as number of tubes (NCNT), back-gate mobility (μFE(back)), 
and gate length (L) are fairly constant across the chip. Most of the FETs have a minimum 
ID around 1 µA and maximum ID around 3 µA, which corresponds with 1/3 of nanotubes 
being metallic and 2/3 being semiconducting. The large counter-clockwise hysteresis is 
expected because the exposed CNTs are subject to shielding and polarization effects of 
water molecules adsorbed to the CNT and silicon oxide under it.28 While the large 
hysteresis might impede biosensor designs based on exposed CNTs, the p-type transistor 
action at this stage is enough to strongly forecast good oxide-covered transistors at the 




2.5.1.2 Metal-Gate CNTFET, Top-Gated 
On the finished biosensor, each of the CNTFETs has its own gate electrode. As is 
not possible in a global back-gating configuration, we can conveniently modulate the gate 
voltage of a single transistor and measure the output and transfer characteristics at the 
probe station (Figure 27). This allows us to characterize the threshold voltage and assess 
any yield problems (such as gate leakage) on a per transistor basis. 
Our paramount quality concerns boil down to two transistor parameters: the 
threshold VTH, and the gate current IG. For automated tracking of the threshold voltage, 
we need a parabolic ID–VGS curve with transconductance high enough so that noise and 
 
Figure 26. (left) Cartoon illustration of back-gate operation of a bare CNTFET in post metal wire 
(MW) stage. The back-gate voltage VBS is applied via the substrate and is global to all CNTFETs 
fabricated on the same substrate. (right) Transfer characteristics of several bare CNTFETs from 
one chip (VDS = 0.1 V). The counter-clockwise hysteresis loop starts at the stars on the left. The 
ohmic back-gate transconductance is |gmb| ≈ 0.05 µS and occurs near VBS = −100 V. The gate 























hysteresis do not interfere. We also need |VTH| < 1 V or so to avoid electrolytic reactions 
that occur at occasional oxide pinholes. Finally, the leakage current of the gate should be 
IG < 1 nA over the intended VGS scan range. 
The direct top-gate transfer characteristic of a representative good transistor is 
shown in Figure 27. Compared to the bare CNTFET of Figure 26, this device is 
ambipolar, has practically no hysteresis, and has a VTH readily identified by our custom 
threshold-tracking software. Furthermore, the top-gate transconductance (red line) is 
nearly 1 µS, which is 20 times the average back-gate transconductance of Figure 26. This 
is nearly four times better than the top/back ratio we predicted in Section 2.3.2! We 
attribute the improvement to a combination of increased modulation of the Schottky 
  
Figure 27. (left) Schematic of direct top-gated CNTFET with metal gate. As a simplification, we 
omit the back-gate substrate, which we short to the source. (right) Direct top-gate transfer 
characteristic of a CNTFET. Device has 30 nm of Al2O3 top oxide and metal-gate of 30 nm Au 
with 1 nm Ti adhesion layer. The ohmic top-gate transconductance (red mark) is |gm| = 0.8 µS. 
The circle marks the threshold location. Direct contact to the GAS was made with a fine (25 µm 






















barriers at the CNT-metal contacts with the high-κ dielectric, plus reduced contact 
resistance due to annealing during the top-oxide deposition. 
2.5.2 Output Characteristic 
So far we have been primarily interested in transfer characteristics (ID–VGS), 
which allow us to easily track the device threshold and measure transconductance. 
However, we can also extract important parameters from the output characteristic (ID–
VDS) such as output resistance and mobility.  
  
Figure 28. Measured output and transfer characteristics of a CNTFET, compensated for metallic 
component (~35 kΩ). (left) Output characteristics (ID–VDS), measured (dots) and from 
calculation (dotted lines) for VGS = 0.5–1.75 V in steps of 0.25 V. Calculations used (NCNT 
μ CG/L) = 5 µA/V2 (extracted from deep ohmic region) and VTH ≈ 250 mV. The drooping in drain 
current at higher VDS may be due to pulling of VTH to higher value. (right) Transfer characteristic 
(ID–(VGS −VTH)) curves for VDS = 0.05–1.25 V in steps of 0.25 V. The VTH shifted from −58 mV 
to 487 mV under increasing VDS. Variations in threshold (VTH) and metallic/offset current 




















































We measured six ID–VDS curves and six ID–VGS curves of a single top-gated 
CNTFET. Both sets of data must be compensated for a significant metallic component 
that would other render the plots unrecognizable. For example, the output characteristic 
with the metallic background included look basically like a diagonal line (resistive). The 
adjusted output and transfer characteristics are plotted in Figure 28. The output 
characteristic also includes curves calculated from (1) and (2) in Section 2.3.1, assuming 
(NCNT μ CG/L) = 5 µA/V2. 
The measured ID–VDS curves are generally in good agreement with their 
calculated counterparts. However, one may notice a drooping in drain current at higher 
VDS, which may be due to pulling of VTH to higher values as semi-mobile charges move to 
shield the higher electric field across the channel. The measured transfer characteristics 
(ID–(VGS −VTH)) follow a highly parabolic trajectory as usual, but according to the model, 
should follow a more linear path at higher gate voltages. In both cases, the threshold 
voltage was not completely constant; in the transfer characteristic, the VTH shifted from 
−58 mV to 487 mV under increasing VDS. 
While it may be possible to apply a more rigorous analysis to explain the 
deviations from theory using first principles, this would be very difficult given several 
unknowns such as the number of CNTs comprising the channel, the nature of their 
complicated interconnections, and the Schottky barriers at the interface of the CNT 
network to the metallic contacts. Rather, we resort to extracting a few key parameters. 
The slope of the output characteristics in the deep ohmic region is the output 
conductance (inverse of the output resistance), which can be used with (5) to provide an 
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estimate of the field-effect mobility. Noting that gds is a function of VGS, we measure an 
average value of kds ≡gds/(VGS−VTH) = 5 µA/V2. This value is used to plot the calculated 
output characteristics in dotted line and was also used in the model of Figure 6. 
The slopes of the transfer characteristics in the deep ohmic region can be used 
with (4) to provide another estimate of the mobility. We extract an average value of km ≡ 
gm/VDS = 11 µA/V2. We will use km and kds and gm from the previous back-gate and top-
gate measurements to calculate mobility estimates.  
2.5.3 Calculation of Field-Effect Mobility 
The mobility of individual carbon nanotubes has been thoroughly investigated by 
Dürkop et al.,7 who extracted field-effect mobilities on the order of 10 m2/V∙s. Since it is 
generally difficult to determine the mobility of the CNT channel itself due to contact 
effects, Dürkop et al. used very long channels (L ≈ 300 µm) to reduce the contribution of 
the contacts. Since our channel lengths are much shorter (L = 10 µm), the contacts are 
more likely to reduce the apparent mobility of the devices. With this caveat in mind, we 
estimate the effective field-effect mobility from measurements on our CNTFETs. 
The estimates of μFE depend on assumptions for the values of the numbers of 
nanotubes and the gate capacitance. We take NCNT = 1 and CG(back)= 20 pF/m and CG(top)= 
100 pF/m. The drain bias VDS is always 100 mV. Using these values, we compute the 
field-effect mobilities, summarized in Table 2. The back-gate transfer characteristic of 
the bare (unpassivated) CNTFET yielded the lowest figure of 0.25 m2/V∙s, while the 
highest figure of 1.1 m2/V∙s was extracted from the direct top-gated transfer characteristic 
of the finished CNTFET.  
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While we hope for the gold standard of 10 m2/V∙s, we realize that these estimates 
are already optimistic because the effective number of CNTs per transistor is likely much 
greater than one. We are also reminded that the effective mobility of our devices is likely 
to be degraded due to contact effects (i.e. Schottky barriers at the metal-CNT interfaces). 
However, our mobilities, on the order of 1 m2/V∙s, are still 20 times better than typical 
silicon devices. 
2.5.4 Fabrication Process Quality Control & Improvements 
The goal of this project is to use our biosensors in a molecular biology 
experiment, rather than to explore the details of various device parameters. Under this 
framework, the fabrication and engineering activities behaved more like a company than 
a research group. We were responsible for producing over 200 biosensors with a certain 
level of quality and consistency amidst fluctuating process parameters as found in a 
research environment. In fact, it was not so much a matter of maintaining quality as it 
was a matter of constantly improving the quality of our devices. 
Table 2. Summary of field-effect mobility estimates extracted from measured transfer and output 
characteristics. 
Measurement gm (µS) CG (pF/m) kds km (µA/V2) μFE (m2/V·s) 
Back-gate 
(Figure 26) 
0.05 20 0.5 0.25 
Top-gate 
(Figure 27) 
0.8 100 8.0 0.8 
Output char. 
(Figure 28) 
varies 100 5 0.5 
Transfer char. 
(Figure 28) 
varies 100 11 1.1 
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In the following, we assess the performance of our biosensors at the chip level 
based on a few key parameters: chip threshold (VTH), chip transistor yield (Y), and chip 
transconductance (Gm). The chip VTH and Gm are simply the average of gm and VTH 
over all the CNTFETs on a chip (or a subset of the 104 FETs on a chip). The yield of a 
chip is defined as the ratio of the number of “good” FETs to the total number of FETs, 
where we define the criteria for “good” later. A “good” chip generally has easily 
distinguishable thresholds within a VGS range that can be accessed without degrading the 
chip due to electrolysis. 
 
2.5.4.1 Advantage of Metal Gate vs. Oxide Gate  
As alluded to earlier in Section 2.4.4.6, one of the major challenges for us was 
controlling the threshold voltage of the CNTFETs. The transistor gate oxide and its 
interface to the outside world turn out to have a major impact on VTH. For convenience, 
we define the shift in chip threshold as ∆VTH ≡ VTHk−VTHk−1, where k is refers to the 
current trial, and k−1 is the previous trial. 
As shown in Figure 29, the VTH of a gateless chip (oxide-covered but before gate 
metallization) is about 1200 mV. (In this special case, the top-gate voltage was applied 
via an electrolyte even before a reservoir was attached.) The direct-gated VTH of the 
finished chip (after gate metallization), is nearly 1400 mV lower. Conversion of the 
finished chip from direct to liquid gating produces a ∆VTH of just 140 mV. Given this 
miniscule shift, one might conclude that the metallization causes a large negative ∆VTH.







ϕϕϕ ++−= 2  (8) 
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where φM  and φS are the respective work-functions of the metal and semiconductor, φF is 
the semiconductor surface fermi level, and σetc is the sum various charges in the oxide 
and at material interfaces.29 The gateless FET is bathed in electrolyte containing mobile 
ions of relatively low work function, suggesting that metallization of the gate should 
cause a threshold increase. Unfortunately this was not observed. Moreover, the similarity 
of VTH of the finished chip under direct and liquid gating suggests that the metal gate 
somehow stabilizes the chip. By process of elimination, our attention is focused on σetc, 
specifically the charges at the interface of the oxide and electrolyte. As will be seen in 
detail in Chapter 4, surface charges comprised of ionized amphoteric sites on the oxide 
surface indeed generate a significant potential that shifts the VTH in the direction opposite 
to their polarity.  
 
 
Figure 29. (left) VTH (over 6 CNTFETs) measured after completion of the following fabrication 
stages: BPED (Bonding Pad-oxide Etch and Deposition), GAS (gold attachment surface), and 
GAS (liquid gated). Error bars indicate one standard deviation. (right) ∆VTH shifts due to GAS 
(vs. BPED) and due to liquid gating vs. direct gating. The shift of −1370 mV is likely due to the 
work function of the metal gate, since liquid gating causes a shift of just +138 mV with respect 































Relative to the metal-gate transistor, the gateless transistor has a quite positive 
threshold, implying negative surface charge. This is quite expected because aluminum 
oxide tends to form negatively charged hydroxyl (-OH) surface groups when exposed to 
water. The variability of this process with respect to ionic concentration and pH is a 
vulnerability that supports the argument for protecting the gate oxide with metal gates. 
Furthermore, the relatively higher spreads of thresholds in both liquid-gated 
experiments suggests that the electrolyte and/or Ag/AgCl electrode may play a role in 
increasing the noise of the system. 
 
2.5.4.2 Controlling Threshold Voltages 
Problems with threshold voltage rose again when we needed to switch the vendor 
providing the ALD oxide growth. As shown in Figure 30, the standard recipe gave us 
VTH fairly close to zero, which is good for avoiding electrochemical degradation. Due to 
material supply issues, we were forced to send three batches of chips to an external 
vendor to perform ALD “for-hire”. The fabrication process was then completed on a 
handful of chips that yielded a batch average VTH ≈ −2000 mV, which would require 
large VGS scan ranges that would cause the loss of many chips. 
We again refer to (8) to solve this problem. The only term we have control over is 
φM. In past experience, chromium and titanium, with work functions of 4.5 eV and 
4.33 eV, respectively, yielded thresholds less than zero. In fact, this is how we made 
many unusable transistors with thresholds from −2 to −4 V. Only a handful of elements 
(Pt, Pd, Ir, Au, and Ni) are available to us with a work function above 5 eV, but most of 
these were also known to have poor adhesion to oxide. Ultimately, palladium (Pd, 
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5.41 eV) proved to move the threshold voltages closer to zero (VTH ≈ −780 mV) and 
provide sufficient adhesion. 
2.5.4.3 Improving Transistor Yield  
Another major problem we faced was a low yield of working transistors per chip. 
A working transistor (“pass”) basically has a clear threshold voltage with low gate 
leakage. A transistor that fails may have a transfer characteristic with undesirable 
properties, such as high gate current, more than one minima in the transfer function, or a 
threshold voltage that is outside of the acceptable range (window). A MATLAB script 
was written to automatically categorize each transistor as “pass” or “fail”. If the 
percentage of good transistors on a chip is more than about 75%, we deem the chip 
worthy of use in molecular biology experiments. 
By far the major symptom of transistor failure was gate current leakage, which 
tends to be super-imposed onto the transfer characteristic when some portion of the gate 
current leaks into the drain current. An investigation was launched to figure out why 
 
Figure 30. VTH of three incremental versions of chips: standard recipe, new vendor for ALD 
oxide, and change in metal gate adhesion material. The new oxide caused a large shift in VTH. 
Change the adhesion layer from Cr to Pd brought the VTH back to a reasonable value. The mean 





















some chips were not yielding any useful number of good transistors. As shown in Figure 
31, the percentage of transistors on a chip with acceptable gate leakage was originally 
62%, with large variation. 
Figure 32 contains two SEM images of our biosensors. The first image is an 
almost “side-view” of a metal layer coated with ALD oxide. Asperities exist on both the 
substrate and metal layer with roughness similar in magnitude to layer thicknesses. The 
other image, a top view of the active area of the CNTFET, shows that significant 
roughness under the gate area is imparted by the presence of CNTs and other presumably 
organic particles in the transistor active area (continually protected from O2 plasma 
cleaning). It follows that the multitude of asperities may hinder the development of a thin, 
uniform conformal oxide.  
This realization prompted the doubling of ALD oxide thickness to reduce the 
chance of gate leakage. As seen in Figure 31, this action resulted in an improvement of 
yield to an average of 91% with full yield for many chips. 
 
Figure 31. Transistor yield vs. ALD oxide thickness for 16 chips using the standard thickness 
(blue) and 22 chips with double thickness (red). Doubling the oxide thickness improved the 
















2.5.4.4 Increasing Transconductance 
 Based on the literature on annealing CNTFETs,16 the metal layer of our early 
chips was a single layer of titanium (Ti) 50 nm thick. Upon realizing that we did not need 
to pursue annealing but needed to decrease the source and drain wire resistance, we 
changed the recipe to 100 nm of gold (Au) on 10 nm of titanium (Ti). The gold, with its 
low sheet resistance, takes the role of the main conductor, whereas the titanium promotes 
adhesion to the substrate and forms intimate contact with the CNTs. As shown in Figure 
33, this resulted in an increase of the average transconductance from 0.6 µS to 2.5 µS. 
 
Figure 32. SEM images revealing source of surface roughness possibly responsible for loss of 
gate isolation. (top) Asperities can be seen on substrate and metal layer on this chip, which has a 
30 nm oxide layer over a patterned 50 nm metal layer. Roughness of surface is similar in 
comparison to layer thicknesses. (bottom) Significant roughness under the gate is imparted by 
the presence of CNTs and other presumably organic particles in the transistor active area, which 
was protected from O2 plasma cleaning. It follows that the multitude of asperities may hinder the 









2.6 Threshold Stability 
It is important to establish the stability of our transistors so that changes in the 
threshold voltage can be assumed to come from nucleic acid hybridization. We assess 
stability in two different experimental configurations: dry direct gating and liquid-gating. 
Direct-gating proves stability of the transistor itself, whereas liquid-gating further tests 
the stability of the electrodes and the transistor immersed in electrolyte. 
2.6.1 Direct-Gating 
To characterize individual transistor stability, we repeatedly scan the direct-gated 
transfer characteristic of one transistor at a probe station. The gold top gate of the 
transistor is contacted by a thin, flexible gold wire so as to not damage the gate or 
underlying oxide. The drain and back-gate voltages are held constant (VDS = 100 mV, VBS 
= 0 V). After visually confirming placement of the probes, the VGS scanning is started. 
Figure 34 shows the threshold voltage of a representative CNTFET over 100 
consecutive scans over a period of eight minutes (a sampling interval of 5.2 s). The VTH 
experiences a significant amount of instantaneous fluctuation but drifts downward from 
 
Figure 33. Transconductance of chips from metal layer version 1 (Ti only) to version 2 (Au/Ti). 















−810 mV and settles at a level of −850 mV. The drift follows an exponential settling 
pattern over the long-term with a time constant of 1.9 minutes. The RMS noise level is 
~11 mV; however, a few large shifts of about ±50 mV exist.  
We postulate that the settling behavior is due to relaxation of the top-gate 
capacitance through a finite gate resistance, which abides by a time constant given by τOX 
= ROXCOXWL, where ROX  is the gate resistance, COX is the gate capacitance per unit area 
(as defined before), W is the gate width (50 µm), and L is the gate length (10 µm). Given 
the measured time constant and gate capacitance of COXWL = 740 fF, we estimate the 
gate resistance is ROX = 160 TΩ. According to data from the ALD oxide company, the 
oxide resistance should be 2000 TΩ. The higher figure achieved by the company may be 
due to the testing method (liquid Hg probe), or better substrate/growth conditions. We 
recall that ALD oxide does not nucleate directly on CNTs. 
 
Figure 34. Threshold voltage of a direct-gated CNTFET over 9 minutes of repeated scanning 
(100 scans). An exponential settling function (red dashed) with a time constant of 1.9 minutes is 
fitted via a least-squares error method. The RMS noise level is ~11 mV. The VGS scan range is 






















Fluctuations in the threshold voltage of CNTFETs are especially expected given 
the small dimensions and high surface to volume ratio of CNTs. Long-term tracking of a 
DC parameter such as threshold voltage is also prone to 1/f noise, which increases at 
lower frequencies. Collins et al.12 found that a wide variety of single- and multiwalled 
carbon nanotube devices (including individual SWNTs, two-dimensional networks, and 
three-dimensional mats) all exhibit a relatively large amount of 1/f noise compared to 
devices made of other materials. This is not surprising given that the current in nanotubes 
is transmitted through surface atoms and is easily perturbed by local charge fluctuations. 
Snow et al.30 investigated 1/f noise in two-dimensional carbon nanotube networks like the 
ones used in this work and found that increasing the device size can reduce the 1/f noise. 
They also postulated that the gate field might also produce charge fluctuations in the gate 
dielectric.  
Rather than perform a full noise analysis to ascertain the physical noise sources in 
our transistors, we conclude that to reduce the effect of 1/f noise, we should avoid the use 
of excessively long measurement durations in an attempt to average out thermal noise. 
For example, it should be sufficient to measure the VTH a few times before hybridization 
and take the mean. Do likewise after hybridization. Since the hybridization signal is the 
shift between two threshold voltages, and given the noise in the settled VTH, it follows 
that the uncertainty in any hybridization signal is about 10 mV at the minimum. 
Like 1/f noise, the observed settling behavior may be due to charges within the 
oxide dielectric which might move under influence of the gate potential. In this 
experiment, the VGS was biased at 0 mV before the scanning was initiated. During the 
scans, the VGS goes from −2000 mV to 0 mV, applying an average of −1000  mV to the 
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gate. This change in average VGS level may have attracted positive charges or repelled 
negative charges underneath the metal gate, causing a gradual negative shift in threshold. 
To avoid this effect, it is imperative to use a symmetrical VGS range.  
2.6.2 Liquid-Gating 
Next we are interested in assessing the stability of the liquid-gated CNTFET 
(Figure 35), which takes into account the interaction of the electrolyte with the reference 
electrode, counter electrode, and metal gate. The threshold voltage of a CNTFET over 
280 successive liquid-gated scans is shown in Figure 36. The VTH began in the vicinity of 
−470 mV and drifted upward by 80 mV to a final level of −390 mV, following an 
exponential settling function with a time constant of 25 minutes. The RMS level of the 
noise is ~25 mV. 
 
 
Figure 35. Schematic of liquid-gated CNTFET after reservoir attachment. As a simplification, 














As in direct top-gating, we again assume that the settling behavior is due to 
relaxation of a capacitance through a finite resistance. However, we must take into 
account additional resistances and capacitances introduced by liquid gating. As is 
explained in Chapter 4, the capacitance at the electrolyte-gate interface is relatively large 
compared to the oxide capacitance. This could easily increase the capacitance term in the 
RC time constant by a factor of 50! Thus, we attribute the longer time constant in liquid-
gating to the electrolyte.  
The noise level in VTH in this liquid-gated setup is about twice the level of the dry 
direct-gated setup. Hassibi et al.31 modeled the noise processes in the ISFET and showed 
that a main source of noise is the electrolyte thermal noise (both in the bulk and the 
diffusion layer). Thus, we also attribute the increased noise to the presence of the 
electrolyte. 
 
Figure 36. Threshold of a liquid-gated CNTFET over 67 minutes of repeated scanning (280 
scans). An exponential settling function (red dashed) with a time constant of 25 minutes is fitted 























We designed, fabricated and tested more than 200 biosensor chips, each 
containing an array of over 100 CNTFETs. The high mobility of carbon nanotubes makes 
them an attractive candidate for high-sensitivity field-effect detection of the intrinsic 
electric charge of DNA and RNA. However, the extraordinarily high sensitivity of CNTs 
is accompanied by poor selectivity. By coating the CNTs with ALD oxide, we strike a 
balance between selectivity and sensitivity.  
Before employing the biosensors in molecular biology experiments, we 
electrically test them for two important parameters: threshold voltage and gate current. 
The thresholds must be easily distinguishable and within a range that can be accessed 
without degrading the chip due to electrolysis. The gate current must be low so as to 
ensure that the metal gate surface is electrically isolated from the rest of the transistor, 
and that the transistor itself is protected from destructive electrolysis.  
We realized the advantages of metal gates as opposed to the typical oxide-only 
gate of an ISFET. The metal gate protects the underlying oxide from chemical etching by 
the hybridization buffer, as well as allows for control of threshold voltages by careful 
choice of the adhesion layer material. Throughout the production of the CNTFETs, we 
improved the transistor yield to over 90%, which is excellent for a research process. 
We characterized the threshold stability of the biosensor under direct gating and 
liquid gating conditions. Our devices have low hysteresis and a settling behavior as 
expected considering the interaction of the electrolyte and gold gate electrodes. 
In practice, all devices exhibit some hysteresis and drift. This may be due to semi-
mobile or slow charges. For example, it is known that the aluminum oxide and its 
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interfaces to other materials trap such charges. These may also explain why the threshold 
voltage depends on the gate voltage range. Once the range has been chosen for a series of 
measurements, it will be kept constant.  
After the biosensors have been fabricated and shown to be electrically 
operational, it is time to functionalize them with the appropriate probe that will target the 
disease of interest. The next chapter will provide an introduction to the disease of breast 





Chapter 3: Introduction to HER2, Existing Testing Methods, & 
Proposed Biosensor 
3.1 Chapter Purpose 
This chapter uses HER2 as a framework to educate the reader about breast cancer 
and molecular biology. We briefly overview established HER2 testing methods and 
present our vision of an integrated lab-on-a-chip system to incorporate the various 
processes required to extract and analyze HER2 mRNA from a sample of cancer cells. 
We review the literature on biosensor research, focusing on the state-of-the-art in direct 
label-free RNA detection.  
We then detail our collaboration with the National Cancer Institute (NCI) to 
design and synthesize high-performance probes for HER2. One HER2 probe was selected 
for the biosensor, implemented in peptide nucleic acid (PNA) technology, and required 
the development and validation of new surface attachment and hybridization protocols. 
Finally we demonstrate validation of the probe with established fluorescent methods. 
3.2 Breast Cancer & HER2 
In 2009, more than 192,000 women were diagnosed with breast cancer in the 
United States.32 The National Cancer Institute (NCI) estimates that this year, 207,090 
more women will be diagnosed, and that nearly 40,000 will die from it.33  
For some fraction of breast cancer patients, a possible treatment is the antibody 
Herceptin® (trastuzumab), which costs nearly $100,000 a year. Insurance is usually 
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hesistant to cover the cost. This treatment is only effective in cases where the cancer cells 
have an overabundance of the HER2 protein, causing them to be more aggressive than 
other types of breast cancer. The aggressive nature of HER2 and the high cost of 
Herceptin® bolster the need for widespread, routine laboratory testing to determine 
HER2 status. 
We embarked on an engineering project with the goal of lowering the barrier to 
HER2 testing via commercialization of an integrated testing system. We provided a 
prototype system that was used at NCI to determine the HER2 status of breast cancer cell 
lines. A commercialized platform must be able to provide valid diagnostic results 
repeatedly, as opposed to a one-off prototype with sporadic performance. 
There are numerous challenges in the adoption of a new technology in a field of 
study that evolved from empirical observation and inferences. Many methods involve or 
have evolved from direct observables such as color change, or fluorescent light emission. 
Furthermore, given the complexity of biological systems, validation based on agreement 
with first principles calculations, as is often acceptable in engineering, is often not 
possible or even necessary in molecular biology. The legitimacy of an experiment is 
based on sound formulation, inclusion of the proper controls, and comparison with 
existing data. We see this methodology as we review established and possible alternative 
testing methods for HER2.  
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3.3 HER2 & Testing Methods 
3.3.1 Background 
HER2 is a receptor protein that resides on the surface of certain cancer cells and is 
associated with higher aggressiveness in breast cancers. All normal cells contain the 
genetic instructions for the production of HER2, which can help promote normal growth 
of the cell. However, in about 25% of breast cancer patients, the cancer cells have an 
excessively high number of HER2 receptors.34 These HER2-positive (HER2+) cells are 
more likely to grow and reproduce uncontrollably when stimulated by growth factors that 
are naturally occurring in the body. 
Research into HER2 has found that overexpression of this receptor is associated 
with increased disease recurrence and worse prognosis. HER2 has been identified as a 
marker of advanced stage breast cancer.35 Even women with apparently benign (as seen 
under a microscope) breast tissue samples that ultimately test HER2 positive appear to be 
at increased breast cancer risk.36 Because of its prognostic role as well as its ability to 
predict response to trastuzumab (trade name Herceptin), HER2 status tests are 
recommended for all invasive breast cancers.37  
3.3.2 HER2 Status Testing 
Testing to determine HER2 status is performed on samples taken from an initial 
biopsy or breast cancer surgery. A core biopsy is the use of a needle to remove a tissue 
sample from a mass or lump. The tissue can then be examined under a microscope and 
submitted for laboratory testing. The basic histology is performed by examining a thin 
slice (section) of tissue under a light microscope. At this point, a limited diagnosis of 
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cancer can be made, such as benign, malignant, or indeterminate. To determine HER2 
status, the tissue must be sent to a laboratory to undergo immunohistochemistry (IHC) 
and/or fluorescence in-situ hybridization (FISH).  
3.3.2.1 Immunohistochemistry (IHC) 
As shown in Figure 37, immunohistochemistry can be used to reveal how much 
HER2 proteins are present, or expressed, on the surfaces of cells. It is basically a staining 
technique that is able to hone in on HER2 by exploiting the principle that antibodies bind 
specifically to matching proteins. In the simplest scheme, the antibody probe contains a 
binding site that matches the HER2 receptor, as well as a reporter dye molecule for 
contrast visualization. For increased sensitivity, a stronger signal can be produced by the 
use of unlabeled primary antibodies that are detected by labeled secondary antibodies 
that bind to it.  
 
Figure 37. Light microscopy images comparing of HER2 expression in primary breast tumors 
via IHC. (left) HER2 expression scored as 0. (right) HER2 expression scored as 3+ (=positive). 
Expression of the HER2 protein was determined on 5-μm paraffin sections by a two-step 
immunohistochemical staining. Following incubation with the primary rabbit antibody (DAKO) 
to human HER2 protein, a secondary goat anti-rabbit immunoglobulin conjugated with 
horseradish peroxidase was applied for visualization. Source: Vinatzer et al. 38 
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Figure 38 illustrates the principle of signal amplification using primary and 
secondary antibodies. The HER2 receptors (antigen A) on the cell surfaces bind with 
primary antibodies engineered from rabbits to specifically probe for HER2. The 
secondary antibody is chosen because it binds only with rabbit antibodies, and was 
engineered to contain a marker, or label, for the purpose of visualization. This indirect 
detection scheme is very sensitive because many molecules of the secondary antibody are 
able to bind to a single primary antibody. The FDA-approved IHC assays HercepTest® 
(DAKO) and Pathway™ (Roche) are based on the principle of indirect 
immunohistochemistry. 
3.3.2.2 Fluorescence in situ Hybridization (FISH) 
Fluorescence in situ hybridization (FISH) checks whether the cancer cells have a 
normal level of HER2 gene copies in the cell nuclei. If the number of chromosomal 
copies of HER2 is higher than normal, this is called gene amplification. Figure 39 
contains fluorescent images from a HER2 normal and HER2 amplified tissue specimen. 
 
Figure 38. Schematic of indirect immuno-cytochemistry. The immobilized antigen A 
corresponds to HER2 receptors on the cell surface. The primary antibody is derived from rabbits 
but is engineered to have a component specific to human HER2 protein. The secondary antibody 
is anti-rabbit (only binds with rabbit antibodies) and is conjugated with a marker, or label. This 
detection method is very sensitive because many molecules of the secondary antibody are able to 
bind to a single primary antibody. Source: MBoC.39 
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The HER2 signals are red, while the reference signals are green. HER2 gene 
amplification is determined from the ratio of the number of signals from HER2 to that of 
centromere 17 is ≥2.0, as required by the U.S. Food and Drug Administration.  
The principle of FISH, illustrated in Figure 40, is the specific hybridization of a 
fluorescent probe nucleic acid sequence with its complementary sequence within 
chromosomal DNA. The HER2 probe spans the entire HER2 gene sequence, as 
determined from a gene sequencing database, and is attached to a fluorophore (i.e., 
SpectrumOrange™, Texas Red®). The prepared sample is incubated with the HER2 
probe. If the probe is complementary to DNA in the chromosomes of the cell, it will 
hybridize with it. Probe that has not hybridized with genes in the cell will be washed 
away. Then the hybridization signals are observed under fluorescent microscope. 
 
Figure 39. Fluorescent images from FISH comparing HER2 gene amplification in primary breast 
tumors in patients showing HER2 signals (red) and centromere 17 signals (green). (left) A 
normal (HER2−) nonamplified specimen. (right) A HER2 gene amplified (HER2+) cancerous 
specimen. Tumors were scored as harboring a HER2 amplification when the ratio of the average 
HER2 copy number to that of centromere 17 was ≥2.0, as required by the U.S. Food and Drug 
Administration for the approval of this method. Source: Vinatzer et al. 38 
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3.3.2.3 Comparison of IHC & FISH 
A comparison of FISH and IHC is shown in Table 3. FISH is currently the gold 
standard because it directly measures HER2 gene amplification at the DNA level. It is 
also expensive ($800/test, billed to patient), due to the labor and reagent costs. Time of 
skilled labor is consumed in preparation, overnight hybridization, and signal counting 
under a microscope. 
 
 
Figure 40. Principle of FISH. Probe DNA sequence, labeled with fluorescent dye, is introduced 
into a cell. The HER2 probe specifically hybridizes with its complementary sequence in 
chromosome 17. After unbound excess probe is washed away, the remaining hybridization 
signals are observed under fluorescent microscope. Source: Dako.40 
Table 3. Comparison of FISH and IHC. 
  FISH IHC 
Overall cost High ($800) Low 
Time to result >4 days >3 days 
Amount of training 
required High  Low 
Internal control Yes No 
Interpretation Objective/quantitative Subjective/qualitative 
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Compared to FISH, IHC is relatively lower in cost, time, and skill requirements. 
Its weakness is that it relies on antibodies, so is prone to false negative and false positive 
results due to inappropriate tissue handling, and may even lead to false positive results 
due to staining artifacts.41 
Both FISH and IHC require tissue samples to be taken from the patient, fixed, and 
embedded in wax. The technique of core needle biopsy uses hollow needles to extract 
cylindrical samples. The needles are up to 1.6 mm in diameter (14 gauge) and 20 cm 
long. The needle is inserted into the person while using ultrasound or another technique 
to identify the approximate location of the suspected tumor. Typically three to six cores 
will be extracted in one session, frozen, and sent to a laboratory for analysis. 
At the laboratory, these samples are dehydrated, fixed in formalin for 18 to 24 
hours, dehydrated in ethanol and xylene, and embedded in paraffin wax. The formalin-
fixed paraffin-embedded (FFPE) tissue sample must then be cut into thin slices of about 
5 µm thickness. Finally, the sections must be dried and frozen. This labor-intensive 
process takes at least two days. 
Neither FISH or IHC is solidly quantitative. For FISH, a specialist must observe 
about two-hundred tumor cells under a microscope, counting the red (HER2) and green 
(CEN-17) signals. Tumors are scored as harboring HER2 amplification when the ratio of 
the average HER2 copy number to that of centromere 17 is ≥2.0 (required by the U.S. 
FDA). In the case of IHC, the criteria are even more subjective. Four scoring levels exist 
(0 to 3+) that correspond to the intensity of the stain. If the tissue scores 0 to 1+, it is 
called “HER2 negative.” If it scores 2+ or 3+, it’s called “HER2 positive.”  
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We have seen two approaches, FISH and IHC, which gauge the presence of 
HER2 at the structure level and the gene level, respectively. Like a blueprint, DNA 
encodes genetic information about the development and function of living organisms, and 
is usually found in the well-known double helix form. Proteins perform many roles in the 
structure, signaling, and enzymatic reactions of cells. Their specific sequences of amino 
acids are indeed generated from corresponding sequences in DNA. 
There is another nucleic acid that acts as an intermediate between DNA and 
proteins. Ribonucleic acid (RNA) serves as a template to convey the information in DNA 
for the synthesis of proteins. The overall process, illustrated in Figure 41, is summarized 
in the central dogma of molecular biology, which states that genetic information in each 
cell of the body is stored in deoxyribonucleic acid (DNA), transcribed to ribonucleic acid 
(RNA), and finally translated into protein. The specific sequences of amino acids 
uniquely identify a protein and indeed are generated from corresponding sequences in 
DNA. 
The amount of specific proteins in a given cell depends upon the expression levels 
of the corresponding messenger RNA (mRNA) that has made its way out of the cell 
nucleus. mRNA is a processed version of the “blueprint” code from DNA and serves as a 
template for translation into protein. Thus, an alternative approach to FISH and IHC 







Figure 41. Schematic of relationships of DNA, RNA, and proteins in the cell.  DNA in the cell 
nucleus is organized into chromosomes. The corresponding genes are transcribed into RNA. 
RNA is processed (non-coding parts are removed) into mRNA, which is moved out of the 




3.3.3 Potential Alternative Testing Methods 
3.3.3.1 Q-RT-PCR 
As a potential alternative for assessment of HER2 status, Vinatzer et al. explored 
quantitative real-time reverse transcription-polymerase chain reaction (RT-PCR) as a fast 
and inexpensive method for producing quantitative results.38 First, they extracted total 
RNA from homogenized tumor tissue and reverse transcribed it into complementary 
DNA (cDNA), which was then amplified by polymerase chain reaction (PCR). Reverse 
transcription is required because the replication enzyme (DNA polymerase) can act only 
on DNA. 
 
PCR is able to amplify target nucleic acid sequences a billionfold (Figure 42). 
Two primers (probes) with sequences that flank the sequence of interest are synthesized 
chemically. Upon mixing with the sample of DNA, PCR proceeds in cycles of heating 
and cooling. Every cycle doubles the amount of DNA as compared to the previous cycle. 
In practice, 20 to 30 cycles are able to produce enough copies of the gene to be detected 
by other methods such as fluorescent hybridization. Variations on the standard PCR have 
evolved since its inception.  
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Quantitative PCR is basically the same as standard PCR but detects the amplified 
DNA as the reaction takes place. Fluorescent signals are detected in real-time as 
fluorescent-labeled gene-specific DNA probes hybridize with their complementary 
targets. The experiment will often target more than one gene; reference targets serve to 
normalize the target of interest. For example, Vinatzer et al. 38 normalized HER2 levels to 
 
Figure 42. Amplification of DNA using the basic PCR technique. (A) Cycle 1, Step 1: 
Denaturation of the double-stranded DNA by heating. Step 2: Hybridization with primers 
targeting region of interest. Step 3: DNA synthesis activated by DNA polymerase. Monomers 
(dATP, dGTP, dCTP, dTTP) extend each primer to form two new daughter strands. (B) Cycle 2: 
Repeat of the thermal cycling yields 4 double-stranded DNA (dsDNA). Cycle 3 yields 8 dsDNA. 
Further cycling produces exponentially increasing copies of dsDNA. Source: MBoC.39 
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those of the β-actin protein to compensate for variability in the amount of cDNA starting 
material. 
Figure 43 shows the normalized levels of HER2 obtained by quantitative RT-PCR 
from two different cancer patients. Statistical analysis was used to determine a cutoff 
level of 30 above which the sample would be scored as HER2 positive. This way, HER2 
status can be determined automatically without the need for a specialist to examine 
multiple images and make subjective judgments. Overall, this method yielded 
comparable correlations of HER2 status with the overall survival of the patients. Thus, it 
could be a promising complement or alternative to current methods for HER2 testing, 
particularly in laboratories lacking FISH or IHC technology. 
 
 
Figure 43. HER2 mRNA expression levels determined with quantitative RT-PCR in primary 
breast tumors of two patients: low relative expression of HER2 (HER2−) and high relative 
expression of HER2 (HER2+), as determined by comparison to a statistically determined 
threshold of 30 (red line). Results are in agreement with HER2 status via IHC and FISH. Source: 





























3.3.3.2 Fluorescent Microarray 
DNA microarray technology, the workhorse of genomic medicine, provides a 
means to simultaneously monitor the RNA expression of thousands of genes. Schena et 
al. published its first use for gene expression profiling in 1995, utilizing high-speed 
robotic printing of DNA on glass.43 The principle behind its operation is straightforward. 
An array of single-stranded probe DNAs are spotted on a chip and followed by a 
blocking process to prevent further attachment of nucleic acids in the non-spotted areas. 
Each element of the array contains a specific nucleotide sequence (chemically 
synthesized) that probes the sample solution for complementary sequences. 
The probe DNA preferentially captures a sequence that is complementary to it, 
and the binding is highly specific since it is stabilized by Watson-Crick55 base pairing in 
which adenine (A) only binds with uracil (U) for RNA or thymine (T) for DNA, and 
guanine (G) with cytosine (C). For example, the sequence 5’-GATTACA-3’ will 
preferentially bind with its complementary RNA sequence, 3’-CUAAUGU-5’ or DNA 
sequence 3’-CTAATGT-5’. The identity of any nucleotide fragment that hybridizes on 
the chip is thus known simply by detecting its location in the array.  
Figure 44 depicts a cancer analysis based on a comparative gene expression 
microarray, which includes cDNA from healthy cells as a control measure. First, genes 
expressed as RNA are reverse transcribed and amplified using PCR. The resulting cDNA 
from the cells under investigation are tagged with a fluorescent red, while the cDNA 
from healthy control cells are tagged fluorescent green. A mixture of both of these 
labeled cDNA is then dropped onto all the elements of the microarray. If a certain gene is 
expressed more strongly of the cancerous cells, the corresponding spot in the array is 
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redder. Conversely, the spot is greener if the gene is not expressed so much as in the 
reference cells. Thus one can use DNA microarrays to generate a profile of the genes that 
are selectively switched on or off to cause cancer. 
As in the case of Q-RT-PCR, the mRNA of interest is likely at such low levels 
that it cannot be detected directly. In this case, RNA from the cells would first be reverse 
transcribed into cDNA, amplified by PCR, and tagged with fluorophore. In reverse 
transcription, the double-stranded cDNA contains the same sequence as the original RNA 
with U replaced by T. The positions in the array that fluoresce are recorded by a 
scanning-laser microscope and cross-referenced back to the known probe sequences.  
A commercialized version of the microarray concept is the Affymetrix GeneChip 
which has an array of over 500,000 known probe DNA sequences synthesized on a 
16 mm square glass surface via photolithography techniques. The Affymetrix Genome-
 
Figure 44. Schematic of comparative gene expression microarray. (a) A robotic spotter has 
deposited DNA probe sequences at each array position. These do not fluoresce because they are 
unlabeled. (b) The entire array is exposed to equal doses of cDNA  from control (green) and 
cancerous (red) cells. (c) After a stringency wash, the remaining fluorescence signal indicates 
how DNA is expressed differently in cancerous cells. If a certain gene is expressed more 
strongly into RNA of the cancerous cells, the corresponding spot in the array is redder. 
Conversely, the spot is greener if the gene is expressed higher in the reference cells. Yellow 
indicates high expression in both control and cancerous cells. 
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Wide Human SNP Array costs $250 per sample and is designed to search for single 
nucleotide polymorphisms (SNPs), changes in just one nucleotide that can significantly 
affect the risk of cancer or other disease. 
The Luminex XMAP platform could be seen as an evolution of the microarray 
concept.  In place of a monolithic glass substrate, the system color-codes polystyrene 
microspheres into 100 distinct sets, each functionalized with a unique probe (Figure 45). 
This allows multiplexing of several probes in one reaction tube. During the measurement 
phase, the probe on any bead is identified via correspondence with the fluorescent 
signature. 
For the purpose of determining HER2 status, it is likely that less than 100 unique 
probes would be needed. In concept, the microarray idea could be scaled back to match 
the requirements at hand. Furthermore, auxiliary processes in the laboratory could be 
integrated into a single miniaturized system. 
 
 
Figure 45. Schematic cartoon of Luminex principle of operation. A microsphere is functionalized 
with PNA probe via carboxyl-amine reaction using EDC. During hybridization, the HER2 RNA 
target (labeled with Biotin) forms a duplex with the HER2 PNA probe. As a final step, the 
biotin-labeled end of the RNA is stained with streptavidin-phycoerythrin (SAPE). Streptavidin 
has a high affinity for Biotin, while phycoerythrin is a fluorophore. During measurement, a laser 
scanner excites and reads the fluorescent signature of the bead and the intensity of the SAPE.  
SAPE
micro-





3.4 Proposed Biosensor 
3.4.1 Lab-on-a-chip Integration 
Q-RT-PCR and microarray are two existing lab methods to indirectly detect the 
overexpression of HER2 at the mRNA level. Our vision of determining a patient’s HER2 
status at the point-of-care calls for the integration of a series of steps that is usually 
performed manually. The process flow common to both methods is generalized in Figure 
46, and involves a series of steps to extract RNA from tissue, amplify the genes of 
interest via PCR, and detect them via fluorescence. Many of these steps are labor-
intensive and must be done in a laboratory with high-cost equipment, reagents, and 
highly trained personnel. To get this system out of the laboratory and into the field, we 
need to reduce the number of process steps, thereby also avoiding the cost of reagents and 
equipment.  
Since DNA polymerase can act only on DNA templates, the mRNA must first be 
reverse-transcribed. If we can directly detect the HER2 mRNA, we could avoid the labor 
and costs of both reverse transcription and amplification. Direct detection of mRNA is 
also biologically relevant because mRNA reveals more or less the exact sequence of 
amino acids in the protein that will be synthesized from it. It follows that therapy is 
possible by blocking bad mRNA from being translated to disease-causing proteins.  
By using CNTFET arrays to directly detect RNA via its intrinsic charge, we can 
also do away with fluorescent labeling. The remaining steps can be integrated and 
miniaturized through the use of microfluidic systems.44 This resulting system could be 




We recognize a number of advantages to our envisioned method. Point-of-care 
testing means tissue will not need to be fixed or embedded in wax, which is known to 
cause unreliability in IHC. Avoiding PCR means avoiding unfair bias in replication due 
to the difference of hydrogen bonds between A-T (2 bonds) and G-C (3 bonds).  
Despite its success, conventional microarray technology will not be the optimal 
platform for our application. Fluorophores are expensive ($300 for 1 µmole of 
oligonucleotides) and difficult to attach to RNA. The array-scanner itself, which detects 
the color intensity is priced more appropriately for research labs than clinics (the baseline 
Affymetrix GeneChip fluorescent array scanner costs over $200,000).  
 
Figure 46. Gene expression assay process flow. After tissue collection, the cells are lysed, the 
RNA is extracted, and the RNA is reverse transcribed into cDNA. PCR amplification multiplies 
the copy number of genes of interest. On a microarray, the genes are labeled, hybridized to 
probes attached to glass, and washed. Finally, results are compiled from fluorescence image 
data. In Q-RT-PCR, fluorescent labeling is integrated with PCR primers to allow real-time 
measurement of gene levels.  Reverse transcription, PCR amplification, and fluorescent labeling 
could be eliminated in a direct, label-free detection scheme. 
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The new challenge we face is in developing a cost-effective RNA detection 
method with enough sensitivity to obviate the need for PCR, and enough selectivity to 
make reliable and repeatable diagnoses. 
3.4.2 Field-Effect Detection of Nucleic Acids 
At biologically relevant pH levels, DNA and RNA bear intrinsic electrical charges 
that could be detected by field-effect transistors. As shown in Figure 47, each nucleotide 
(nt) consists of a base (G, T, C, or A), a sugar ring, and a phosphate group. In RNA, the 
sugar ring is ribose, whereas the sugar ring in DNA is deoxyribose (ribose lacking an 
oxygen atom). Multiple nucleotides are linked together covalently via the oxygen atoms 
of the phosphate groups. Three of the oxygen atoms in a phosphate participate in two 
bonds. But one of the oxygen atoms participates in a single bond, leaving an unshared 
electron. This is the origin of the negatively charged character of the sugar-phosphate 
backbone. 
The quest to detect charged molecules in aqueous solution via the field-effect 
transistor dates back to 1970, when Bergveld introduced the ion-sensitive field-effect 
transistor (ISFET).45 The ISFET combined the principles of glass reference electrodes 
and the MOSFET to measure ion concentration. The introduction of silicon as a substrate 
for making such measurements opened the possibility of integrating the sensor with 
conventional CMOS circuitry such as amplifiers and signal conditioning. This approach 
has been so well-developed that they are the basis for Honeywell's line of Durafet Non-





Figure 47. Chemical structure of the DNA molecule. Each base (G, T, C, or A) is covalently 
attached to one sugar (deoxyribose) and a phosphate group (PO3−), comprising a nucleotide. The 
nucleotides are linked together covalently through the sugar-phosphate backbone, formed by the 
3′-hydroxyl (-OH) group of one sugar and the 5′-phosphate (P) of the next. The phosphate group 














A review of silicon-based chemical sensors making use of the field-effect concept 
was given in 2003 by Bergveld.17 More recently, a summary of DNA or gene field-effect 
transistors, or “GenFETs”, was compiled by Poghossian et al.47 The first attempt in the 
direct detection of a hybridization event via a GenFET was reported by Souteyrand et 
al.48 in 1997 in which they observed a shift in flat-band voltage of a FET (10 nm gate 
oxide) about 100 mV for the hybridization of ~2 μg/mL of 1000-mer poly(dA) to 
immobilized 1000-mer poly(dT). Fritz et al. in 2002 reached a hybridization detection 
sensitivity of 2 nM of 12-mer (8 ng/mL) DNA via differential measurements at 1 kHz on 
a capacitive sensor with 2 nm of thermally grown oxide.49 Perkins et al. observed 
threshold shifts on the order of mV in response to the hybridization of 1 μM 15-mer DNA 
on depletion mode floating gate FETs,50 while Pouthas et al. built a linear FET (10 nm 
oxide) array and observed a 10 mV response to the deposition (but not hybridization) of 5 
μM of 20-mer single stranded DNA.51 They also observed a 50 mV shift in response to 
the deposition of 20 μg/mL of double stranded DNA. Refinements by Ingebrandt et al.52 
allowed them to detect a signal amplitude of 4 mV using a chip-to-chip differential sensor 
readout for target concentrations of 1-3 µM. 
Based upon the literature, the field-effect detection of nucleic acids is nothing 
new. However, the direct detection of mRNA will present some unique challenges. 
3.4.3 State of the Art in Direct Detection of mRNA 
It has already been shown that Q-RT-PCR can be used to detect the HER2 at the 
mRNA level, but indirectly. If we can avoid the reverse transcription and amplification 
altogether, we can avoid the associated labor and reagent costs. Direct detection of 
mRNA might yield better results because mRNA reveals the exact sequence of amino 
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acids in the protein that will be synthesized from it, whereas cDNA is known to contain 
biases and artifacts induced by PCR amplification.53 
We face a number of challenges in direct detection of RNA. RNA is chemically 
unstable, due to the polar hydroxy group on the ribose sugar. RNA-digesting enzymes are 
ubiquitous and careful handling is required throughout experiment. The biggest challenge 
may be specifically detecting the very low levels of HER2 mRNA relative to all the other 
RNA in the cell. About twenty million strands of RNA are present, including messenger 
RNA, transfer RNA, ribosomal RNA, and others types. Detecting the HER2 mRNA, 
which might be present in just 50 strands, is like finding a needle in a haystack. In a real 
life situation, HER2 would be further diluted. In a biopsy sample taken from a patient, 
affected (cancer) cells are mixed with healthy cells and cells from other tissues. Also, 
hybridization could be hindered by the natural tendency of RNA to form loopy secondary 
structures.  
3.4.4 Peptide Nucleic Acid (PNA) Probe Technology 
In 1991, Nielsen et al. reported on the design and synthesis of peptide nucleic acid 
(PNA),54 an artificial DNA mimic that follows Watson-Crick55 base pairing with DNA 
and RNA but with high stability and sequence-selectivity. PNA molecules also exhibit 
excellent chemical stability and resistance to enzymatic digestion.56 
These desirable traits are based on the fact that its pseudo-peptide backbone, 
substituted in place of the charged sugar-phosphate backbone, is electrically neutral 
(Figure 48). Therefore, PNA is highly suitable as a probe molecule since it does not 




The high specificity of PNA/RNA duplex formation means that a single base 
mismatch can be discriminated against better than a similar mismatch in a DNA/RNA 
duplex. The success of PNA as a probe for RNA is attested by the fact that a vast 
majority of published studies have focused on PNA oligonucleotides that target mRNA. 
In fact, it is also possible for PNA to form triplexes with double-stranded chromosomal 
DNA.58 Hence, cell penetrating PNAs are being sought for gene therapy or silencing. 
The application of PNA as probes for DNA hybridization arrays was 
demonstrated as early as 1997.59 More recently, PNA has been used in microarrays by 
Jacob et al. in 200460 and 2006.61 PNA has been used in the direct detection of DNA 
using nanowire sensors by Hahm and Lieber,62 and on CNTFETs by Maehashi et al.15 
In our application, a very important aspect of PNA is that it can hybridize with 
target RNA in the complete absence of salt in the hybridization buffer. This helps us 
 
Figure 48. The backbone of PNA is composed of repeating N-(2-aminoethyl)-glycine units 
linked by peptide bonds. The bases are the same four bases found in DNA (A, C, G, T). Since 
the backbone of PNA contains no charged phosphate groups, the binding between PNA/RNA 




avoid contaminating the transistor gate oxide with mobile ionic contaminants, as well as 
allows for higher detection signals due to less screening. It also opens to the door to the 
possibility of real-time monitoring of the transistor thresholds as the hybridization 
reaction is occurring, which is not possible with DNA probes, which require high 
strength buffers that drown out the signal.  
Furthermore, in a low salt environment, the target RNA is less likely to maintain 
secondary folding structures and more likely to be linearized and accessible to 
hybridization with the probe. This also allows us to avoid the fragmentation of long RNA 
before hybridization. Longer RNA could potentially increase the measured signal if the 
more remote tails do form secondary structure or otherwise lay flat on the transistor, 
bringing more charge within the Debye screening length. 
Although PNA is relatively easy to synthesize, it is not widely commercially 
available for customized use and has seen limited application (i.e., the chromosome 17 
probes in the HER2 FISH pharmDx™ Kit). Since custom PNA probes are not 
commercially available, our collaborators at the NCI designed and synthesized PNA 
probes for this and other efforts such as targeted delivery and gene therapy.  
3.5 Results: Design, Synthesis, & Validation of HER2 probe 
In close collaboration with our NCI chemist, we produced multiple HER2 PNA 
probe sequences and validated their performance on a proven, commercially-available 
nucleic acid detection system. Bioinformatics specialists at the NCI designed a unique set 
of probe sequences to specifically capture HER2.  The probes were then synthesized and 
purified using in-house peptide synthesis techniques. After the probes were validated 
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using an accepted molecular biology platform, we collaborated to develop and validate 
the probe attachment chemistry relevant to our biosensors. 
3.5.1 Design of HER2 Probe Sequences 
The design of HER2 probe PNA sequences was based on the existing 
bioinformatics techniques used to design DNA probes, but with modifications that 
basically account for the stickiness of PNA. Whereas the HER2 probe DNA in FISH may 
extend the entire HER2 gene (~41,000 base pairs), a PNA probe needs to be fairly short 
(16 nt) to avoid spontaneous aggregation due to poorer water solubility. 
As a starting point for probe design, our molecular biologist at NCI used the 
HER2 probe sequences from the Affymetrix gene chip, which has 25-mer DNA probes. 
(Since the DNA-DNA binding is relatively weak, duplexes shorter than 25-mer may 
simply melt at room temperature.) Using these 25-mer windows to the HER2 gene, a 
protein sequence database (PSD) and other bioinformatics methods were used to search 
for 16-mer PNA sequences within these windows with high melting temperature.63 
Candidate sequences were checked against specific design rules that ensure solubility in 
aqueous solutions and avoid self-complementary.  
Table 4 contains the sequence and relevant calculations for the HER2 PNA probe 
sequence selected for use on the biosensor. The melting temperature Tm is the 
temperature at which half the population of PNA-DNA duplexes are denatured. Tm is 
important because the duplexes melt at lower temperatures when the buffer has less ionic 
screening. However, higher temperatures may be needed for high specificity. The 
sequence must also satisfy the following rules on purine content: (a) the purine (adenine, 
guanine) content must be ≤ 60%, (b) the number of any purines in a row must be ≤ 4, and 
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(c) the number of any guanines in a row ≤ 3. The HER2 probe sequence shown obeys 
these rules and is suitable for synthesis.  
A chemical drawing of the probe is shown in Figure 49. The modification of this 
particular version of the probe is for surface attachment via an acrylic-sulfur bond. The 5’ 
acrylic group is coupled to the main PNA sequence via a spacer that increases the 
solubility of the entire molecule. The acrylic group can be replaced with the appropriate 
functional group to match the groups on the attachment surface. The subject of 
attachment chemistry will be discussed next. 
Table 4. Sequence and calculation results from Applied Biosystems, Inc. (ABI) for the anti-
sense HER2 PNA probe suitable for synthesis. Anti-sense polarity means the probe can detect 
mRNA directly, as opposed to a sense probe for detecting cDNA from reverse-transcription. 
The melting temperature (Tm) decreases with lower ionic strength. The probe modification 
(mod) is attached to the 5’ end.  
HER2 probe 5’-(mod)-ACT GGA CCC TAG AGT C-3’ 
Complementary 
target 
           3’-TGA CCT GGG ATC TCA G-5’ 
Tm ([1 µM]) 76 °C  
Tm ([1 nM]) 64 °C 
Tm ([1 pM]) 53 °C 
Molecular weight 4369.8 g/mol 
% purine 50.0% Limit: 60% 
Longest purine 
stretch 
4 (AGAG) Limit: 4 mixed A/G, 
3 G in-a-row 
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3.5.2 Attachment Chemistry 
A variety of options exist for attaching nucleic acid probes to surfaces. The choice 
of attachment chemistry involves determining what reactive group will be used to modify 
the probe and what surface groups must be available for reaction. Amino, thiol, and 
acrylamide are among the routinely used modifications in conventional microarrays. In 
 
Figure 49. Chemical drawing of acrylic-modified HER2 anti-sense PNA probe. 5’ acrylic group 
is on the upper right. The 16-mer PNA sequence is linked to the acrylic group by an 11-atom 
PEGylated (polyethylene glycol) spacer. The distance created by spacer increases the 
accessibility of the acrylic group for immobilization and the nucleotides for hybridization. The 






























































































































































these cases, the issues affecting the decision revolve around fluorescence performance 
(scattering, background), as well as chemical stability and loading capacity. 
In our case, we wanted a simple probe attachment strategy that would also 
maximize hybridization loading capacity. Given the choice of gold CNTFET gates, it 
followed that two options existed: functionalization of the gold surface with a self-
assembled monolayer (SAM) followed by covalent attachment reaction, or direct 
attachment of thiol-modified probe to the gold. 
The first option was used by Maehashi et al.15 to attach PNA probes to the back 
gate of CNTFETs. It involves incubating the bare gold surface in a solution of 3-
mercaptopropionic acid to form the intermediate SAM, then activation of carboxylic acid 
groups using an aggressive coupling agent (ethyl-3-[3-
dimethylaminopropyl]carbodiimide hydrochloride, or EDC).  After activation of the 
carboxy function with N-hydroxysuccinimide (NHS), the 5'-amino-modified PNA may 
then be attached.  
Ultimately we adopted the simpler option and synthesized PNA with 5’-thiol 
modifications (Figure 50). Thus we avoided the difficulties we encountered with the 
moisture sensitivity of EDC and could run the attachment reaction in the mild conditions 
of DI water. This attachment strategy was used by Steel et al.64,65, who achieved nearly 
complete target hybridization levels on gold surfaces. They also were able to enhance the 
accessibility of the probes for hybridization by blocking unreacted surface sites with 6-
 
Figure 50. Cartoon drawing of thiol (HS) modification, PEG spacer, and PNA sequence. Thiol 
group is intended for direct attachment to gold (or other noble metal) via dative bond.  




mercapto-1-hexanol (MCH). However, we employed the basic sulfur-gold chemistry and 
will defer the exploration of blocking to a later optimization phase. 
3.5.3 Synthesis & Purification 
The PNA was synthesized via Fmoc chemistry solid phase peptide synthesis66 and 
purified using high-performance liquid chromatography (HPLC). In short, peptides are 
synthesized by coupling the carboxyl group of one amino acid to the amino group of 
another. Protection groups based on 9-fluorenylmethyloxycarbonyl (Fmoc) prevent 
unwanted side reactions on the developing oligomer until which time the next nucleotide 
should be appended.  
The ABI 433A Peptide Synthesizer was used to make the crude probe PNA, 
which will contain a mixture of the desired product and other unwanted fragments. The 
Agilent 1200 series HPLC was used to isolate the desired product (Figure 51). As 
compared to automated DNA synthesis, peptide synthesis is more difficult. Thus, the 
purification step here is more important than for DNA oligos, since peptide synthesis 
often does not perform at high efficiency. Matrix-assisted laser desorption/ionization 
(MALDI) was used to measure the distribution of molecular weights of compounds 
within the purified product. The MALDI spectrum of successful PNA synthesis shows 




We collaborated with NCI to verify the performance of the exact HER2 PNA 
sequence that we would be immobilizing on our biosensors. Validation was performed on 
two different fluorescent-based systems: (1) the commercially available Luminex XMAP 
platform, and (2) plain gold surfaces. Luminex was used to generate quantitative 
calibration curves (intensity vs. target concentration) to find the optimal temperature for 
specificity. The plain gold chips were then used to qualitatively demonstrate successful 
hybridization and specificity of the same probe sequence but different attachment 
chemistry.  
 
Figure 51. (left) Applied Biosystems ABI 433A Peptide Synthesizer used to make probe PNA. 




3.5.4.1 Validation via Luminex XMAP 
The Luminex experiment involves immobilizing probes to the Luminex 
microspheres (beads), then hybridizing them at 55 °C with synthetic, biotin-modified 
RNA. After hybridization, the biotin-RNA is stained with streptavidin-phycoerythrin 
(SAPE) fluorophore; streptavidin binds strongly with biotin. During measurement, a laser 
scanner reads the fluorescent intensity from the SAPE bound to the RNA. Since 
hybridization occurs in a 96-well plate, it is convenient to test several concentrations and 
different targets in parallel.  
As shown in Table 5, a sense-polarity probe and three different sequences of 
biotin-labeled synthetic RNA were used: fully complementary wild-type (wt), single 
nucleotide mutation (mt1), and two nucleotide mutations (mt2). The sense-polarity probe 
is intended for capturing HER2 in PCR-amplified cDNA that is reverse transcribed from 
cellular mRNA. The mutant targets constitute single and double nucleotide 
polymorphisms and are included to test the specificity of sequence recognition. 
 
Table 5. HER2 “sense” probe and synthetic target sequences used in Luminex experiment. The 
sense polarity probe is designed to detect cDNA from reverse transcription-PCR. Mutated 
nucleotides are underlined. 
Probe 5'-/amine/GAC TCT AGG GTC CAG T-3' 
Wild type (wt) 5’-/biotin/ACU GGA CCC UAG AGU C-3’ 
Mutant 1 (mt1) 5’-/biotin/ACU GGA CUC UAG AGU C-3’ 
Mutant 2 (mt2) 5’-/biotin/ACU GGA CUC UAG CGU C-3’ 
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The protocols for probe immobilization and target hybridization are summarized 
in Table 6. The microspheres are pre-functionalized with carboxylic acid groups 
(COOH). The attachment chemistry is similar to the EDC/NHS method used by 
Maehashi et al.15 The 5'-amino-modified PNA is directly mixed with the beads while the 
acid groups are activated with EDC in acidic conditions (pH 4.5). The conjugated beads 
are then washed in detergents and resuspended in TE storage buffer. 
Hybridization was at 55 °C in 50 µL of buffer based on Tris-EDTA, followed by 
SAPE staining. No explicit washing step was incorporated because the measurement 
procedure further dilutes the beads and the unbound SAPE, producing a negligible 
background. 
Calibration curves (fluorescent intensity vs. synthetic RNA concentration) are 
shown in Figure 52. As expected, each curve shows an increasing signal with increasing 
Table 6. Summary of Luminex XMAP protocol for attachment of probes to Luminex 
microspheres, hybridization with synthetic DNA, and fluorescent staining. 
Probe Immobilization 
1. Dilute one million beads (106) in 10 µL MES buffer, pH 4.5. 
2. Add 1 µL of NH2-modified PNA probe (100 pmol). 
3. Add EDC (5 µg, 2.5 µL) and 30 min at room temp (repeat once). 
4. Wash the conjugated beads with 0.02% Tween20 and 0.1% SDS. 
5. Resuspend in 20 µL TE pH 8.0. 
6. Count the beads under a hemacytometer (~5,000 beads/µL). 
Hybridization 
1. Dilute the conjugated bead (5000 beads) in 33 µL 1.5x TMAC per well. 
2. Add biotin-labeled target DNA/RNA in 17 µL TE.  
3. Denature at 95 °C for 2 min, then hybridize at 55 °C for 1 hour. 
4. Wash the bead with 1 mL 0.06x SSC buffer and recover the beads by 
centrifugation. 
5. Add 75 µL SAPE (3 µg/ml) in 1x TMAC and 45 °C 10 min. 
6. Measure fluorescence intensity on Luminex-100. 
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RNA concentration. The probe successfully discriminates between RNA that is fully 
complementary and RNA that has point mutations. The fully complementary wild-type 
sequence produces the highest signal overall, while increasing the number of mutations 
caused decreased signals. At concentrations below 0.25 nM, the PNA probe cannot 
discriminate between one mutation and two mutations in the target. Therefore this 
number is claimed as the sensitivity limit. 
 
Figure 52. Luminex calibration curves (fluorescent intensity vs. synthetic RNA concentration) of 
HER2 PNA probe hybridized with synthetic RNA of three different sequences: wild-type (wt), 
single nt mutation (mt1), and two-nt mutation (mt2). The fluorescence signal originates from 
streptavidin-phycoerythrin (SAPE), which binds with biotin on the labeled RNA. Hybridization 
is at 55 °C in 50 µL Tris-EDTA buffer containing trimethylammonium chloride (TMAC). Each 
curve shows an increasing signal with increasing concentration. The fully complementary wild-
type sequence produces the highest signal overall, while increasing the number of mutations 
caused decreased signals. At low concentrations (<0.25 nM), the PNA probe cannot discriminate 
between one mutation and two mutations in the target. The lowest concentration used was 





















For our application, it may not be necessary to detect single nucleotide mutations. 
In a future design, several HER2 probes would be used and the determination of HER2 
status would be based on signals over the aggregate. Thus the overall selectivity is more 
important than the selectivity with respect to a single nucleotide. 
3.5.4.2 Verification on Gold Test Surfaces 
The attachment chemistry and type of surface may affect the hybridization 
performance of the probe. We performed experiments using the exact probe on surfaces 
similar to that which comprises the CNTFET metal gates. Table 7 summarizes the 
protocols for probe attachment and target hybridization. The thiolated PNA probe was 
attached to the gold surface simply by incubation. The hybridization was carried out with 
biotinylated synthetic DNA targets at 55 °C. As in Luminex, visualization is 
Table 7. Summary of protocol for attachment of probes to test surface, hybridization with 
synthetic DNA, and fluorescent staining. 
Probe Immobilization 
1. Heat PNA to 55 °C for 2 mins. Agitate. 
2. Apply spots of 1 mM PNA solution to chip. 
3. Hold overnight in humidified enclosure. 
4. Rinse chip with TGB gently, decant, and blow dry. 
5. Mount to chip carrier. Wirebond. Mount cups using silicone adhesive.  
6. Cure adhesive overnight. 
7. Dilute stock DNA in hybridization buffer. Make 25 µL per cup. Vortex and apply. 
Hybridization 
8. Hybridize in sealed chamber at 55 °C for 3 hours with humidity. 
9. Preheat blank hybridization buffer to 55 °C. Rinse cups twice.   
10. Remove cups and silicone residue. 
11. Mix 2.5 µL SAPE in 245 µL TMAC. Apply under a cover slip, wait 15 mins. 
12. Rinse gently with 0.1X SSarc. Remove as much as possible. 
13. Image chip on Typhoon 9410 with Cy3 setting. 
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accomplished via a final staining step (SAPE). A flatbed laser scanner was used to image 
the results. 
The fluorescent images in Figure 53 show the successful immobilization and 
hybridization of the HER2 probe on gold surfaces. First, a piece of gold-coated wafer was 
split into two chips. One of the chips was hybridized with wild type DNA (WT) and 
produced bright spots only at the areas where the probe was spotted. The other chip was 
hybridized with mutant (MT2) and produced only dim signals. A third chip was patterned 
with PMGI stripes to check if it intereferes with immobilization or hybridization. The 
process is not hampered by the presence of the PMGI protective layer. Furthermore, 
absence of signal over the PMGI stripes indicates that probe does not adsorb to the 
PMGI. 
(a)   (b)  
Figure 53. Representative fluorescent image of synthetic DNA targets hybridized with thiolated 
HER2 PNA probe immobilized on gold coated wafer. The targets were labeled with biotin and 
stained with SAPE, then imaged by Typhoon 9410 Variable Mode Imager. (a) A quarter-circular 
piece of wafer was split into two chips. The entire left chip was hybridized with wild type DNA 
(WT) and produced bright spots only at the areas where the probe was spotted. The right chip 
was hybridized with mutant (MT2) and produced only dim signals. (b) Another gold chip was 
patterned with PMGI stripes and attached to two plastic tubular cups. The probe was spotted 
inside the cups in the bright circular areas. Both spots were hybridized to wild type (WT). The 
absence of signal from where the PMGI is indicates that the probe was not adsorbed to the 
PMGI.  
WT       MT2 




We envision a lab-on-a-chip integrated system for the detection of cancer. For this 
iteration of platform development, we specifically focused on the HER2 breast cancer 
gene and designed, synthesized, and verified custom PNA probes. PNA imparts the 
advantages of high sensitivity and high selectivity under low ion conditions, traits 
important to the success of a reliable diagnostic system. We hope that this system, which 
detects HER2 at the mRNA level, could be used adjacent or in competition with existing 
HER2 status methods based on fluorescence and or antibody staining. In the next chapter, 
we will show that the prototype system was able to detect overexpression of HER2 in real 




Chapter 4: Theory of Operation 
4.1 Chapter Purpose 
This chapter seeks to develop the theory of operation of the CNTFET biosensor 
for the purpose of estimating how much DNA or RNA must be captured to produce a 
measurable signal, as well as what fundamental limitations might govern the maximum 
signal that could be generated. The double-layer theory, based upon the laws of drift and 
diffusion, will be used to explain the operation and purpose of all the electrodes that are 
immersed in the top-gate liquid: the counter electrode, reference electrode, and gate 
 
Figure 54. Schematic diagram of a liquid gated CNTFET, including counter, reference, and gate 
electrodes, all in contact with the top-gate electrolyte. The electrolyte potential is controlled by 
the counter electrode, measured by the reference electrode, and is capacitively coupled to the 















electrode (see Figure 54). The double-layer model will be combined with basic 
electrostatic equations to arrive at the Grahame equation, which gives the relationship 
between surface charge and measurable voltages in solution. We will see that this 
relationship is linear for low densities of nucleic acid, but is moderated at higher 
densities. Finally, we will use the linear relationship to generate a circuit model to gauge 
the sensitivity of nucleic acid detection. 
4.2 Overarching Theory of Electric Charges in Solution 
The principle of operation of the CNTFET biosensor is derived from basic theory 
that describes the distribution of charges when a solid electrode is immersed in a liquid 
electrolyte. The arrangement of the charges is referred to as a “double layer”. 
Suppose a negatively charged electrode is immersed in a liquid electrolyte (see 
Figure 55). The electrolyte consists of dissolved positive and negative ions (for example, 
Na+ and Cl− in pure water). The charges on the electrode will be counterbalanced by a 
cloud of charge in the liquid called the “diffuse layer”. The surface charges and the 
diffuse layer comprise a “double layer”. 
Near the surface of the solid, the diffuse layer is mostly positive ions (attracted by 
the negative solid). However, this dense concentration of positive charge will tend to 
attract a somewhat lesser dense layer of negative ions from the liquid. This layer of 
negative charge will then attract a less dense layer of positive ions. Further out into the 
fluid bulk, this “layering” will continue but with decreased intensity until some distance 
where the electrolyte is practically neutral (bulk region). 
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The structure of the diffuse layer is a consequence of two phenomena: drift and 
diffusion. Drift current depends on electric field and follows Ohm’s Law: V = IR, where 
V is the voltage across resistor R with current I flowing through it. Diffusion is the 
entropic spreading out of particles due to thermal agitation.  
4.2.1 Fick’s First Law of Diffusion 
The diffusion current is directly proportional to the concentration gradient. This is 
the basis for Fick’s First Law of Diffusion: 
 
Figure 55. Simplified model of charges in an electrochemical half-cell, consisting of the 
electrolyte, electrode, and their “double-layer” interface (x = 0). The bulk region of the 
electrolyte contains an equal density of positive and negative ions. The electrons on the electrode 
surface are due to the ionization of atoms on the metal electrode and their subsequent 
dissolution. The charges on the electrode will be counterbalanced by a cloud of charge in the 
liquid called the “diffuse layer”. The double-layer is comprised of the surface charges and the 
diffuse layer.  
electrolyte
electrode
+ + + +






− − − − −−
+ + +
− −









dnqDJ D −=  (9) 
where JD is the diffusion current density (A/m2), q is the charge per particle (C), D is the 
diffusion constant (m2/s), n is the local concentration (number density) of the charges 
(1/m3), and x is the location (m). The negative sign means that the flux of particles is 
opposite to any increase in particle density. (The diffusion constant D must be positive) 
The total current density due to drift and diffusion is J = JE + JD, where JE is the drift 
current density (A/m2).  
4.2.2 Ohm’s Law & Diffusion 
The drift current is directly proportional due to the applied electric field. Thus, the 
relevant form of Ohm’s Law is  
 EJ E σ=  (10) 
 
where JE is the drift current density (A/m2), σ is the conductivity (S/m), and E is the 
electric field (V/m). To combine Fick’s Law and Ohm’s Law, we seek a way to relate the 
conductivity to the diffusion constant. In the absence of any “drag” (scattering 
mechanisms), an electric field accelerates charges to infinite velocities. In reality, charges 
accelerate only until they have reached a “drift velocity”. Thus, a microscopic view of 
Ohm’s Law is expressed as JE = qnv, where v is the drift velocity. The drift velocity is 
directly proportional to the electric field: v = µE, where µ is the mobility. (Note: as used 
here, the mobility is negative for negative charges).
 
For a system in thermal equilibrium that obeys Boltzmann statistics, the diffusion 
coefficient is related to the mobility by the Einstein relation: D = µ (kT/q), where k is the 
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Boltzmann constant (1.38 × 10−23 J/K) and T is temperature (K). We can rewrite the 
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4.2.3 Nernst-Planck Formula  
We rewrite (12) to arrive at the Nernst-Planck Formula, which combines the 






























































Now integrate both sides with respect to x: 
 















In the bulk electrolyte (for large x), the electrolyte ionic density is n0 and the 
potential is zero (φ = 0). Therefore, replacing x’ with x, we arrive at the Nernst relation: 









4.2.4 Nernst Relations 
For simplicity, we will assume that the electrolyte is composed of singly ionized 
species such as Na+ (q = +qe) and Cl− (q = −qe), where qe is the elementary charge 
(+1.609 × 10−19 C). We write separate Nernst relations for each polarity of charge: 













where p(x) and n(x) are the number densities of positive and negative ions, respectively, 
and the “thermal voltage” is UT = kT/qe (~26 mV at room temperature). We also note that 
the bulk electrolyte contains an equal density of positive and negative ions, so it is not 
necessary to define p0 = n0. 
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We can now make the following observations. The density of positive ions is 
highest (and the density of negative ions is lowest) near the negatively charged electrode. 
This is expected, since opposite charges attract and like charges repel.  
4.2.5 Boltzmann Distributions 
























(these may look familiar in study of semiconductor diodes). This result shows that 
concentration at any point depends exponentially on the electric potential. Suppose the 
electrode potential is at −100 mV relative to the electrolyte. Since 
exp(−(−100 mV)/26 mV) = ~47, the concentration of positive ions at the electrode is 
about 50 times that of the bulk (p = 47 n0), whereas the concentration of negative ions is 
about 2% that of the bulk (n = n0/47). 
4.3 Electrodes 
Now that we have presented the basic theories concerning the electrochemistry, 
we will use them to gain an understanding of how the electronic biosensor works. In 
particular, we will explain the operation and purpose of all the electrodes that are in direct 
contact with the top-gate liquid: the counter electrode and reference electrode (Figure 
56). An electrode and the electrolyte around it form a basic electrochemical half-cell.  
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4.3.1 Electrochemical Half-cell 
A simple half-cell is comprised of a metal electrode immersed in an electrolyte, 
an aqueous solution of the metal’s salt (see Figure 55). We are familiar with half-cells as 
they comprise the common alkaline battery. The chemical reaction occurring at either 
pole is either oxidative or reductive. A typical anodic (oxidation) reaction involves a 
metal atom from the electrode being oxidized and dissolved into the electrolyte. The 
reaction can be written as: M ⇌ M+ + e-, where M is a metal atom, M+ is the metal ion, 
and e- is an electron. 
The newly freed electron stripped from the metal atom remains on the electrode, 
 
Figure 56. Top-gate electrode combination. A glass capillary tube surrounds the silver-silver 
chloride reference electrode. The counter electrode is a coiled platinum (Pt) wire. They are both 
mounted in a nylon screw. A plastic tube serves to hold a small amount of top gate buffer to keep 








which acquires negative charge. The newly ionized metal atom contributes positive 
charge to the electrolyte. The reaction proceeds forward until the buildup of electric 
potential no longer favors the generation of metal ions. In accordance with the theory 
presented earlier in this chapter, a double layer of charge forms at the interface between 
the electrode and electrolyte. This equilibrium is reached almost instantly in an isolated 
half-cell. 
The Nernst relations as presented earlier are applicable to the half-cell. If we only 
consider the negative ions, the relevant equation is: 






Let us rearrange the Nernst relation as:














The potential of the electrode with respect to the electrolyte is given by: 
 

















where nelectrode is the negative ion density just outside the electrode.  
Note that negative ions are less dense near the negative electrode (nelectrode < n0) 
due to electrostatic repulsion. As expected, the Nernst relation yields an electrode 
potential that is negative with respect to the electrolyte (φelectrode < 0). 
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In practice, we want to know the potential of the electrode with respect to other 
electrodes in the electrolyte. Also, nelectrode may not be easily determined. Thus, a more 
practical form of the Nernst equation for the chemical reaction is written as  
 ( )00 ln cUEE TN −= , (26) 
 
where EN is the electrode potential, E0 is the standard electrode potential for the reaction, 
and c0 is the ionic strength in molar. EN and E0 are both taken with reference to a standard 
electrode (not the electrolyte). Values of E0 have been tabulated for many electrodes 
through measurement in a standard half cell, usually with reference to the standard 
hydrogen electrode. A standard half cell consists of a metal electrode in a 1 M aqueous 
solution of the metal's salt at standard temperature (298 K, or 25 °C).  
Note that the theory presented is developed assuming equilibrium conditions, with 
zero net current flowing into the electrode. Practical electrode systems can be modeled 
using two extreme cases: ideal non-polarizable electrodes and ideal polarized electrodes. 
As shown in Figure 57, a non-polarizable electrode has a well-defined potential given by 
the Nernst relation and independent of current flow, whereas an ideal polarized electrode 
permits no current flow at any potential. In reality, a practical electrode will be some 
combination of the two theoretical extremes. 
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4.3.2 Ag/AgCl Reference Electrode 
In the biosensor system, a reference electrode senses the potential of the top-gate 
electrolyte (TGE) while charge is driven by a platinum (Pt) counter electrode. Thus, the 
reference electrode should have a stable and well-known potential with respect to the 
TGE. In addition, this electrode need not conduct significant current because it will be 
part of a high impedance circuit. Thus we seek an electrode that has the character of an 
ideal non-polarizable electrode under low current conditions. 
The silver-silver chloride electrode (Ag/AgCl) is used commonly as a reference 
electrode in pH sensors due to its low cost and good performance (see Polk2006).67 It is 
composed of a mixture of silver metal (Ag) and its chloride salt (AgCl). Once immersed 
in solution, the following chemical equilibrium reactions occur: Ag0(s) ↔ Ag+ + e−, and 
AgCl(s) ↔ Ag+ + Cl−. As in our simple model of the half-cell, some portion of 
the electrode dissolves while electrons are left behind on the electrode. However, since 
 
Figure 57. I-V curves of an ideal non-polarizable electrode and ideal polarized electrode. (a) The 
non-polarizable electrode has a well-defined potential given by the Nernst relation and 










silver is insoluble, the net balance of the two reactions is such that the introduction of 
electrons to the electrode releases chloride ions into solution: AgCl(s) + e− ↔ Ag0(s) + 
Cl−.  
In field use, a reference electrode is usually encapsulated in a saturated electrolyte 
for greater stability. The construction of a commercial Ag/AgCl reference electrode, 
illustrated in Figure 58, is based on a silver wire coated at one end with Ag/AgCl. The 
electrolyte interacts with the field environment via a porous frit that is ion permeable.  
In our system, the reference electrode is immersed directly into the top-gate 
electrolyte, which is buffered to provide a stable pH. We can use the Nernstian relation 
(EN = E0 – UT ln(c0)) to calculate the electrode potential for a model situation.  
The standard electrode potential of the Ag/AgCl electrode against the standard 
hydrogen electrode (SHE) is E0 = 230±10 mV. A typical ion concentration in our 
experiments is c0 = [Cl−] = 1 mM. Thus, the potential of the reference electrode is 
EN = E0 + 180 mV = 410 mV with respect to the SHE. If we wish to determine the drop 
 
Figure 58. A commercial reference electrode is based on a silver wire coated at one end with 
Ag/AgCl, housed in a plastic body filled with electrolyte. The electrode assembly interacts with 








from the electrode to the electrolyte, we would rather measure than calculate directly. 
However, it is useful to know the expected variation in the potential drop given changes 
in ionic strength. This is calculated by substituting ln(10) log(c0) for ln(c0) in the 
Nernstian: EN = E0 – UT ln(10) log(c0). This shows that each decade increase in ionic 
strength causes a decrease in electrode potential of about 60 mV. Thus the sensitivity of 
any detector relying on Nernstian potential is limited to –60 mV/decade. For example, pH 
sensors, which measure the concentration of hydrogen ions, have a maximum sensitivity 
of 60 mV/pH. 
4.3.3 Counter Electrode 
In the biosensor, the role of the counter electrode is to modulate the potential of 
the electrolyte. Since the electrolyte should only be charging the double-layers at the 
reference electrode and the transistor gates, the counter electrode normally drives small 
currents. 
If there are short-circuits through oxide pinholes or defective transistor gates, the 
electrode may take the burden of faradaic currents generated by chemical reduction or 
oxidation of a substance at the electrode. Under these conditions, it is desirable for the 
electrode to be chemically inert but it is not necessary for the counter electrode to be an 
ideal non-polarizable or ideal polarized electrode. 
The noble metals (gold, platinum, etc) and glassy carbon are common examples 
of materials used to make counter electrodes. The counter electrode in our system is 
made of platinum, which will not chemically react with the electrolyte.  
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We can safely neglect the details of the potential drop from the counter electrode 
to the electrolyte, since the potential of the reference electrode will simply be a constant 
offset from the electrolyte potential. 
4.3.4 CNTFET Metal Gates 
The gates of the transistors in our biosensor are electrically floating films of gold. 
They are isolated from the rest of the transistor by dielectric and from the bulk electrolyte 
by the double-layer. Under normal circumstances, no electrochemical reaction should 
occur on them that would produce faradaic currents. Thus they are best modeled as ideal 
polarized electrodes. The double-layer model and Nernst relations presented earlier will 
serve to model the capacitive coupling of the gates to the electrolyte. In addition, more 
comprehensive models account for the possibility of ions adsorbed directly on the 
electrode surface. We will move forward to develop these models to describe the theory 
of operation. 
4.4 Biosensor Theory of Operation 
In the case of direct field-effect detection, we wish to measure the electrical 
charge on DNA or RNA (macroions) tethered to the gate of a transistor. We have already 
modeled how a diffuse layer of counterions balance a layer of surface charge on an 
electrode. Now we extend the double-layer theory to describe the response of the 
biosensor to a sheet charge density. 
The theory of ion distributions in aqueous solutions was initiated almost a century 
ago by Gouy68 and Chapman,69 who applied the Poisson-Boltzmann theory to calculate 
the spatial distribution of monovalent ions near a uniformly charged interface. (Prior to 
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this, Helmholtz made the assumption that any surface charges on an immersed electrode 
would be neutralized by a sheet of counterions placed at one ionic radius away from the 
surface. However, this does not occur in nature.) The Gouy-Chapman model proposes 
that a layer of charge at a solid surface is neutralized by a layer of adsorbed counterions 
(via van der Waals interaction) as well as a diffuse region of increased counterion 
concentration in aqueous solution. The effect of excess salt concentration was extended 
by Debye and Hückel.70 In 1924, Stern71 accounted for the finite ionic radius by 
introducing a layer of ions, now called the Stern layer, located near the charged interface 
with a different dielectric constant. Most recently, Pouthas et al. provided a clear 
theoretical picture of the operation of a GenFET.51 The following arguments assume a 
monovalent 1:1 electrolyte (such as NaCl).  
4.4.1 Poisson-Boltzmann Formula  


































where ρq is the local charge density, and εw is the permittivity of the solution, usually 
taken to be similar to that of water (~80 ε0). 
The local charge density includes both positive and negative charges: 
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 ( ) ( ) ( )( )xnxpqxq +=ρ . (29) 
Combining the Poisson formula with the Boltzmann distributions, we arrive at the 
Poisson-Boltzmann formula: 











= . (30) 
 
Now, if we define the geometry and boundary conditions (potentials), we can 
solve for the profile of the electric potential, as well as field and charge. Later, we will 
develop the theory further to solve the electrostatics given a certain density of DNA on 
the transistor. 
4.4.2 Debye Screening Length 
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The Poisson-Boltzmann formula (30) can be written as: 













= . (32) 
 
Now we see that the solutions will involve the Debye length within exponentials. 
At room temperature (T = 300 K) in a solution of 1:1 monovalent salt, the Debye length 









where [c] is the bulk ionic concentration specified in molarity (mol/L). We will show 
soon that the Debye length determines the severity of counterion screening. 
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Suppose a sheet of charge exists at x = 0. Via application of Gauss’ Law, the 
electric field due to the sheet charge is E = σs/εw, where σs is the surface charge density, 
and the field points away from the charge if the charge is positive. By definition, the 
electric field is equal to the negative of the gradient of potential: E = −dφ/dx. Thus, a 
solution to the Possion-Boltzmann formula must satisfy the boundary condition 
dφ/dx = −σs/εw at x = 0. 
For small enough potentials (φ(x) < UT), approximate solutions for the electric 
















which are valid for a weakly charged surface (σs < εw UT / λD) and x > 0. Furthermore, the 











It is now clear that the Debye length characterizes the spatial decay in electric 
field strength. This screening effect means that biomolecules do not feel one another until 
they are very close, but also means that their interactions can be very specific to their 
detailed shape. This allows for highly specific complementary nucleic acid binding and 
protein-antibody binding.  
We illustrate the impact of Debye screening with the following toy model. A 
typical buffer for DNA hybridization has an ionic strength of 150 mM. The Debye length 
in this solution is 0.31 nm/√(150 mM) ≈ 0.8 nm. Now assume a length of hybridized 
double stranded DNA (dsDNA) is attached perpendicular to a surface. Given that one 
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base pair (bp) of double stranded DNA (dsDNA) is 0.34 nm long, only the first two bases 
pairs will contribute to the electric field as the intrinsic charges on the third base pair and 
beyond would be heavily screened by the electrolyte.  
Let us take the liberty to reduce the ionic strength of the buffer to increase the 
Debye length. Selective recognition requires probes to be at least 16 nucleotides long,72 
or 5.5 nm from end to end. The required Debye length should be longer than this in order 
to detect the charge of the hybridized DNA; an electrolyte of less than 3 mM ionic 
strength is required. 
Decreasing the ionic strength of the hybridization buffer to 1 mM results in a 
Debye length of about 10 nm, or about 29 mers. Steel et al.64 measured surface densities 
of 25-mer DNA immobilized on gold of (1−10) × 1016 m-2. At the lower density of 1016 
m-2, the DNA are spaced at a square pitch of 10 nm. This equates to a charge density of 
σDNA = −25 qe×1016 m-2= −40 mC/m2. According to our approximation, the potential drop 
from the bulk electrolyte to the sheet charge is φEC = (−σDNA λD / εw) = (40 mC/m2) 
(9.8 nm)/80ε0 = 550 mV. This voltage would be easily measureable but exceeds the 
bounds of approximation (UT ≈ 25 mV). We would need to scale back the DNA loading 
by 20 times to be at that limit. We now proceed to develop an exact solution to the 
electrostatics. 
4.4.3 Grahame Equation 
We continue to develop the model of operation, which is based on the Grahame 
Equation. For the purposes of the model, we will assume that the CNTFET can be 
modeled as a planar FET and the DNA is in direct contact with the top gate oxide. Minor 
adjustments will need to be made for presence of the gold transistor gate. We will also 
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ignore potential drop from the reference electrode to the electrolyte since this potential is 
invariant with respect to the hybridization process. 
A cartoon model of charge vs. position is shown in Figure 59, which illustrates 
how the DNA charge is screened partially by the FET and partially by the electrolyte. 
The diffuse screening charge of the electrolyte is described by the double-layer and 
characterized by the Debye length. By Kirchoff’s Voltage Law (KVL), the gate-source 
voltage (VGS) is the sum of the potential drops from the Ag/AgCl reference electrode to 
the source: VGS = φRE + φEI + φOX, where φRE is the electrode-electrolyte drop, φEI is the 
electrolyte-gate drop, and φOX is the gate-source drop. For simplicity, the counter 
electrode is not shown, and we neglect φRE because it is invariant with respect to the 
charge of the DNA. Thus, VGS = φEI + φOX. 
The electric field in the oxide is Eox = φOX / tox. By Gauss’ Law, the potential 
across the oxide is φOX = −σFET tox /εox, where tox is the thickness of the top oxide and εox 
is its permittivity. The gate voltage VGS is known because it is applied by a voltage 
 
Figure 59. Simplified schematic of CNTFET electrostatic model. The charge on the FET and 
DNA is screened by the diffuse layer, characterized by the Debye length (λD). By Kirchoff’s 



















source. Therefore, the remaining task is to find the drop from the electrolyte to the 
interface (φEI ) as a function of DNA charge density (σDNA). From this point, we will 
follow the recent treatment by Pouthas et al.51  
The Gouy-Chapman model proposes that the layer of DNA charge would be 
neutralized by the diffuse layer as well as a layer of adsorbed counterions (via van der 



















A schematic representation of the charge density, electric field and potential 
profile of our device, which we treat analogous to a MOSFET, is shown in Figure 60. At 
the oxide-electrolyte interface, there are two important sheet charges: the surface charge 
σ1 is mainly due to the ionization of amphoteric sites on the oxide surface, and the 
positive compact layer (also known as the Stern layer) charge σ2 is due to adsorbed 
cations with loci at the plane of x = δ. On the right of the Stern layer is the sheet of DNA 
charge σDNA, which is negative due to phosphate groups on the DNA backbone. The 
charge on the transistor is σFET, located at x = −tox. 
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The total charge prior to the diffuse layer is σeff = σ1 + σ2 + σDNA + σFET. Then the 
electric field just to the right of x = δ is by Gauss’ Law: E = σeff/εw. Therefore the diffuse 





















This equation, a form of the Grahame equation,73 shows that potentials of greater 
magnitude can be expected with increasing charge density and longer Debye lengths. The 
result of the Grahame equation is plotted as a function of charge density for several ionic 
concentrations in Figure 61a. At low ionic strength (1 mM), the charge sensitivity is quite 
 
Figure 60.  Charge density ρ, electric field E, and potential profile V through FET, oxide, and 
electrolyte (not to life scale). The charge on the transistor is σFET, located at x = −tox. The surface 
charge σ1 is mainly due to the ionization of amphoteric sites on the oxide surface, while the 
charge σ2 is due to adsorbed cations with loci at the plane of x = δ. Immediately to the right is the 
sheet of DNA charge σDNA, which is negative due to phosphate groups on the DNA backbone. 
The diffuse layer balances the net of all of the aforementioned charges. The electric field in the 
oxide is Eox. 
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high but only for low charge density. At high ionic strength (1M), the sensitivity is 
relatively lower but is approximately linear over a larger range. In either case, the arsinh 
begins to reduce the charge sensitivity once φEI  > 2UT ≈ 50 mV. The sensitivity roll-off 
is especially severe when φEI  > 200 mV. 
Suppose a feedback system works to maintain the gate voltage VGS such that σFET 
is always zero. Equivalently, we can track the threshold voltage over several scans of the 
transfer characteristic, where we assume the channel conduction is lowest because σFET = 
0. In either case, φOX = 0, and the gate voltage is simply VGS = φEI. If we further assume 
σ1, σ2 are insignificant, then σeff  = σDNA; any change in the gate voltage is equal to only 
the Grahame potential from the DNA hybridization.  
Let us estimate how much voltage could be generated by a reasonable DNA 
loading. Our previous estimate of 550 mV was satisfyingly large but out of the range of 
approximation. Let us take σDNA  = −40 mC/m2 as before, and assume σ1, σ2, and σFET are 
zero, so σeff  = σDNA. The Grahame equation predicts a resulting voltage of φEI = 160 mV, 
which, although much less than our original estimate, would still be easily measurable. 
Let us further explore the dampening effect of the hyperbolic sinh and the 
possibility of linearization. Define σ0 ≡ 2 UT εw / λD. Figure 61b shows that the arsinh 
does not have much significance for low charge densities (|σeff| < σ0), corresponding to 
φEI  < 2UT ≈ 50 mV. We call the regime the linear range, in which the charge sensitivity 
is |∂φEI / ∂σeff| = λD /εw. This opens the possibility for creating a linear circuit model. 
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At higher charge densities (|σeff| > σ0), the charge sensitivity is significantly 
moderated. Using the identity arsinh(x) = ln(x+(x2+1)1/2), we see that for x >> 1, arsinh(x) 
≈ ln(2x). Thus although this region is less sensitive, there is no fundamental limit 
restricting the magnitude of the potential at ever larger loading densities. 
4.4.4 Circuit Model 
We now formally incorporate the CNTFET, electrolyte, and reference electrode 
into a single electric circuit (Figure 62). The circuit contains the gate-source voltage 
source (VGS) as well as two capacitors: the Debye capacitance (CD), and the FET oxide 
   
Figure 61. (a) Potential drop from the bulk electrolyte to the charged interface as a function of 
charge density (σeff ) with ionic concentration as a parameter. At high ionic strength, the charge 
sensitivity is lower but the linear range is wider. At low ionic strength, the sensitivity is higher 
but the linear range is smaller. (b) (solid) Potential drop from the bulk electrolyte to the charged 
interface as a function of normalized charge density (−σeff  / σ0). (dotted) Plot of 2UT (−σeff  / σ0) 
for reference. For small charge density (|σeff | < σ0), the response is approximately linear. For 


































capacitance (COX). By Kirchoff’s Voltage Law (KVL), the gate-source voltage (VGS) is 
the sum of the potential drops from the reference electrode to the source: VGS = φEI + φOX, 
where φEI is the electrolyte-gate drop, and φOX is the gate-source drop.  
To aid in circuit analysis, we simplify the Grahame equation. First, we neglect σ1 
and σ2 such that σeff = σDNA + σFET. Second, we approximate arsinh to unity for small 
charge density (|σeff | < (2 UT εw / λD)). Using this linear approximation, φEI = −(σDNA + 
σFET)/CD, where CD ≡ εw/λD.  
The oxide capacitance is defined as COX  ≡ εox/tox. Then φOX = −σFET/COX, where 
the negative sign is consistent with Gauss’ Law. Combining this with the approximation 












Solving for the FET charge: 
 
Figure 62. Electrical schematic diagram of biosensor. CD is the Debye capacitance, and COX is 












































In the deep ohmic region (VDS << (VGS−VTH)), the current-voltage relation for a 
standard MOSFET can be approximated as ID = μ (W/ L) VDS COX (VGS−VTH). (In 
experiment, we apply a VDS of 100 mV and VGS on the order of 1000 mV). The drain 
current can be decomposed into two parts: the first part is μ (W/ L) VDS, which has units 
of m2/s. The second part is COX (VGS−VTH), having units of C/m2. By observation, we 











Thus, the threshold is directly proportional to the DNA charge, and the sensitivity 
is simply given by −1/CD. The Debye capacitance is the only capacitance that plays a role 
in shifting the threshold of the biosensor in response to the capture of nucleic acids. If we 
want to maximize sensitivity, we should seek to minimize the Debye capacitance by 
using a buffer with as low ionic strength as possible. 
4.4.5 Tradeoff: Sensitivity vs. Linear Range 
In the linear region, the sensitivity of the threshold shift in response to DNA 
charge is given by |∂VTH / ∂σDNA|= 1/CD = λD /εw = 0.31 nm/([c]1/2 80 ε0 ). From the 
previous section, we already know that lowering the ionic strength increases the 
sensitivity, but also decreases the linear input range.  
We take the optimal DNA loading as the highest density of DNA such that the 
charge on the FET and DNA obey |σDNA + σFET| < σ0 (≡ 2 UT CD). In other words, the sum 
of the DNA and FET charge is such that the threshold voltage is VTH = 2 UT = 51 mV. 
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Suppose a feedback system works to maintain the gate voltage such that σFET is always 
zero. Equivalently, we can track the threshold voltage, where we assume the channel 
conduction is lowest because σFET = 0. In either case, φOX = −σFET/COX = 0, VGS = φEI, and 
σeff  = σDNA; any change in the gate voltage is equal to only the Grahame potential from 
the DNA hybridization.  
Thus the optimal DNA charge density is σDNA = −2 UT CD = 2 UT εw / λD ≈ −[c]1/2 
118 mC/m2, which is basically determined by the buffer ionic strength. The optimal DNA 
loading as a function of buffer strength is shown in Figure 63, where each decade 
increase in ionic strength allows for a √10 (≈3.16) increase in DNA loading.  
We again assume 25-mer DNA with density on the order of 1016 m-2 (Steel et 
al.64). The optimal ionic concentration for linear response is in the regime of 100 mM. In 
the case that higher sensitivity is more important than linearity, a lower ionic strength 
buffer may be used. For a 1 mM buffer, the optimal DNA loading is 3.6 mC/m2, which 
corresponds to a square pitch of 33 nm and areal density of 1015 m-2, which suggests that 
  
Figure 63. Optimal DNA loading vs. ionic strength of measurement buffer. The optimal loading 
is taken as the highest possible density of 25-mer DNA still in the linear range. Each decade 
increase in ionic strength allows for a √10 (≈3.16) increase in DNA loading. The extreme of 
10−7 M ionic concentration represents deionized water. 



































if linearity is of paramount importance, we may want to increase the spacing between the 
probes using spacer molecules.74 Alternatively, we can choose to tolerate the roll-off in 
sensitivity at higher loading levels. 
4.5 Conclusion 
We developed the theory of operation of the CNTFET biosensor beginning from 
the basic laws of drift and diffusion. The double layer model leads to the Nernst relations, 
providing an understanding of the double-layer model as it applies to electrodes in 
electrolytes, as well as serving as the basis of the Grahame equation. We found that no 
fundamental limitations restrict the maximum signal that could be generated by DNA 
hybridization, but that there is a finite range of DNA densities over which the electrical 
response is linear. The choice of buffer strength determines the tradeoff between 





Chapter 5: Biosensor for HER2 Overexpression in Breast 
Cancer Cells 
5.1 Chapter Purpose 
This purpose of this chapter is to show that the prototype HER2 detection system 
was successful in detecting HER2 overexpression in real breast cancer cells. In 
collaboration with the NCI, we developed protocols for immobilizing the probe, 
hybridizing the RNA on the biosensor, and determining status of HER2 at the mRNA 
level. We demonstrated consistent dose-response behavior wherein higher RNA 
concentration produced larger hybridization signals. Over-expression of HER2 breast 
cancer gene in HER2 positive cancer cells was gauged relative to two types of 
experimental controls. The first is detection of the GAPDH house-keeping gene alongside 
HER2 for the purpose of normalization. The second is to use a HER2 negative cell line 
for reference. We were able to discriminate between the two cancer cell lines based on 
the relative HER2 expression level. 
The direct detection of label-free mRNA has not been highly documented in the 
literature. We may be the first to accomplish the discrimination between two cancer cell 
lines via direct detection of label-free mRNA. 
5.2 Detection of Total mRNA from Cancer Cells 
Before delving into detection of HER2 mRNA from cancer cells, we focused on 
detection of generic mRNA as a stepping stone from prior success in using DNA probes 
to detect synthetic DNA targets. Like synthetic DNA oligomers, most RNA molecules 
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are single-stranded. However, biological RNA is more challenging to work with for two 
major reasons. First, naturally occurring RNA comes in a wide variety of sizes (lengths) 
and shapes. RNA molecules tend to form self-loops and take on complex three-
dimensional structures. Second, RNA is generally difficult to work with because it is 
chemically unstable. The sugar-phosphate backbone of RNA is weaker due to the free 
hydroxyl group in the ribose ring.  
Total RNA includes messenger RNA (mRNA), ribosomal RNA, and transfer 
RNA. In this experiment, we targeted messenger RNA (mRNA), which are distinguished 
from other RNA in that they have a 3’ polyadenine (poly(A)) tail which protects them 
from enzymatic degradation and promotes their export from the cell nucleus for 
translation. If we were able to detect mRNA despite the presence of other RNA in this 
mixture, the stage would be set for specifically detecting HER2 mRNA. 
5.2.1 Methods 
The methodology of this preliminary experiment is to generate a basic dose-
response (or standard) curve that relates the threshold shift of the biosensor with the 
concentration of total RNA applied during hybridization. A schematic of a dose-response 
curve is shown in Figure 64a. The response is linear over a finite range of concentration 
but saturates above a certain limit, often due to maximum loading of the probe molecule. 
Below the limit of detection (LOD), the response is “in the noise” and is not significant. 
Our goal is to experimentally determine what range of RNA concentration is the “sweet 
spot” (approximately linear regime) of the biosensor, while being above the limit of 
detection and below saturation. 
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As described in Section 4.4.3, the Grahame equation (37) captures the relationship 
between the areal density of RNA charge and the measured voltage, which strongly 
depends upon the Debye screening length of the buffer. For an ionic strength of 1 mM, 
this relationship is plotted in Figure 64b, which can be used to infer the amount of RNA 
charge per unit area based on the measured voltage shift in the transfer characteristic. In 
theory, given the relationship between the concentration of RNA (#/m3) in the 
hybridization buffer and the areal density (#/m2) achieved due to hybridization, one could 
predict the voltage response to RNA concentration. However, it is difficult to know the 
concentration-binding relationship ahead of experiment.  
Cellular RNA was harvested from live MCF7 breast cancer cells cultured from 
cryogenically frozen stock at the Advanced Technology Center (ATC) of the National 
  
Figure 64. (a) Schematic of a dose-response or standard curve. The response is linear over a 
finite range of concentration. Below the limit of detection (LOD), the response is “in the noise” 
and considered zero. Above a certain limit, the response saturates. (b) Potential from electrolyte 
to gate interface as a function of effective surface charge density. Dashed line is logarithmic 





























Cancer Institute (NCI). The MCF7 breast cancer cell line was originally isolated from a 
woman in 1970 and was the first mammary cell line that was capable of lasting longer 
than a few months. Cells were cultured over several months to provide ample supply of 
RNA for this project. In cell culture, the cells grow in plastic flasks containing a liquid 
media that provides appropriate pH and nutrients. The cancer cells reproduce until they 
are so crowded that they must be either split among two new flasks (see Appendix: How 
to Passage Cells) or chemically lysed to extract the RNA (see Figure 65). If the cells are 
too dense, nutrients will be depleted and the cells will die. Total RNA was extracted from 
the cancer cells via the Qiagen® RNeasy MiniKit protocol, eluted in RNase-free 
deionized water (Qiagen) to a stock concentration of about 420 ng/µL, and stored at 
−80 °C until use. 
 
  
Figure 65. (left) Cancer cells being scraped from bottom of cell culture flask during RNA 
extraction under laminar flow biological containment hood. One flask contains about 7 million 
cells. (right) Magnified view of MCF7 cancer cells adhering to the bottom of a cell culture flask 




We developed a 16-mer poly-thymine (poly(T)) PNA probe to selectively target 
mRNA (see Table 8). This probe can easily hybridize to mRNA since it can bind to any 
consecutive string of 16 adenine bases along the poly(A) tail, which is more than 200 
nucleotides long.  
To functionalize the biosensor for experiment, the freeze-dried poly(T) PNA 
probe was diluted in DI water purged with nitrogen and applied to the chip at a 
concentration of 1 mM and volume of 50 µL. After overnight incubation, the chip was 
rinsed with 0.1X TE (Quality Biological TE pH 8.0 diluted down to 1 mM with RNase-
free water), which was also used as the default top-gate buffer (TGB) during threshold 
scans. The functionalized chip was then plugged into the measurement platform and 
scanned repeatedly to gauge stability. To prepare for hybridization, the chip was taken off 
the platform and excess TGB was removed. The hybridization was performed by 
pipetting the RNA (in 25 µL of TGB) into the reservoir and incubating for one hour at 
room temperature in a sealed humid environment. After a manual rinse with TGB, the 
chip was scanned to acquire the post-hybridization thresholds. 
5.2.2 Results 
As shown in Figure 66, chip-averaged threshold (VTH) shifts of 72 mV and 
99 mV occurred in response to two different dilutions of total RNA: (A) 25 ng/µL and 
Table 8. Probe sequence and structure of mRNA. UTR = untranslated region. 
Probe 5'-/thiol/TTT TTT TTT TTT TTT T-3' 
Target 5’-/cap/5’UTR/Coding Sequence/3’UTR/AAA…AAA/-3’ 
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(B) 50 ng/µL. With the exception of these two hybridization signals, the shifts between 
any two consecutive scans (“repeats”) were miniscule in comparison. During the 13 scans 
between the two hybridizations, the threshold drifted at an average rate of −5  mV/scan. 
An exponential settling function with a decay time constant of 30 minutes was fit to these 
13 scans.  
5.2.3 Analysis & Discussion 
The dose response data of Figure 67 are increasing as a function of the total RNA 
concentration, as expected. We also performed a hybridization with 1374 ng/µL of 
unrelated synthetic oligos (data not shown), which produced a shift of only 17 mV, 
suggesting that the probe is specifically detecting mRNA.  
 
Figure 66. (left) Biosensor threshold (VTH) shift and (right) VTH running total probing for total 
mRNA  in two concentrations of total RNA extracted from breast cancer cells. Hybridizations at 
25 ng/µL (prior to scan A) and 50 ng/µL (prior to scan B) produced shifts of 72 mV and 99 mV, 











































Since doubling the dose of RNA did not produce twice the signal of the first dose, 
the sensor is not responding linearly. The apparent saturation in response at the higher 
RNA dose could be due to the probe being loaded by the first dose. In a strict sense of the 
dose-response, each experiment should start with a fresh chip that has never been 
hybridized before. 
It is also possible that the surface charge of the tethered RNA is so dense that we 
are seeing the inherent non-linear response of field-effect detection. From Section 4.4.5, 
we see that any response greater than 50 mV is already outside of the “linear” regime of 
the Grahame equation. Using the Grahame equation (37) and Figure 64b, we back-
calculate that a response of about 100 mV implies an RNA surface charge density of 
10 mC/m2. Assuming that the effective length of each RNA is 25 mers (approximately 
the Debye length), the RNA density is σRNA/(25qe) = 0.25 × 1016 m−2, or equivalently a 
square pitch of 20 nm. A reasonable estimate of the probe density is twice the RNA 
density (hybridization efficiency of 50%), or 0.5 × 1016 m−2. This is an order of 
magnitude lower than the densities of ~5 × 1016 m−2 measured by Steel et al.64  
 
Figure 67. Signal (threshold shifts) of biosensor targeting mRNA from two increasing 
concentrations of total RNA extracted from the MCF7 breast cancer cell line. The amount of 

















MCF7 total RNA (ng/µL)
 131 
 
The area of probe immobilization, on the gold gates, is 1.5 × 10-7 m2. With the 
probe loading at ~1016 m−2, the total number of PNA probe molecules is 1.6 × 109. The 
number of mRNA floating in solution is estimated using an average molecular weight of 
500,000 g/mol to be 7.5 × 1010 molecules. The ratio of floating mRNA to probe PNA is 
~50, suggesting that we are still far from completely capturing all the target molecules in 
solution. While our estimate of the probe loading seems low, it is important to increase 
both probe loading and hybridization efficiency. Herne & Tarlov74 showed that a tradeoff 
exists; if the probe loading is too high, hybridization efficiency decreases. However, one 
can create just the right probe density by inserting spacer molecules between adjacent 
probe molecules to prevent steric hindrance.  
The negative drift following each hybridization appears to have a time constant of 
30 minutes, which is consistent with the time constant of 25 minutes as we found the 
liquid gating experiment in Section 2.6.2. Therefore the settling behavior probably 
originates from the slow relaxation of charges in the electrolyte equilibrating with the 
transistor gate.  
Let us now get a grasp of the clinical relevance of the detection sensitivity. A 
typical mammalian cell contains about 20 pg total RNA. Using the 5% estimate, the 
amount of mRNA in one cell is about 1 pg. The lower concentration of total RNA in this 
experiment contained 630 ng total RNA. Given that mRNA makes up less than 5% of 
total RNA, our system was detecting less than 32 ng of mRNA. This implies our system 
was detecting mRNA from less than 32,000 cells. For comparison, a core biopsy of 1 mm 
in diameter and 2 mm in length could be expected to yield one million cells. 
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5.3 Detection of HER2 mRNA from Cancer Cells 
Given the positive results from the experiments probing for generic total mRNA 
from real cancer cells, we were ready to probe specifically for HER2 mRNA in two 
different cell lines. The SKBR3 breast cancer cell line is HER2-positive (HER2+) and 
overexpresses HER2 mRNA,75 whereas MCF7 is HER2-negative (HER2−) and expresses 
HER2 mRNA at a normal level.76 
Before we move into the details of the experiments, let us briefly examine the 
challenge we are facing. One cell contains about twenty million strands of RNA from 
many different genes. Of these, just over a million strands are messenger RNA, 
amounting to about 1 pg of mass. Now we want to detect HER2 specific mRNA, of 
which there are as many as 52 copies in the SKBR3 cell or as little as a single copy in the 
MCF7 cell. All else being equal, we are aiming to measure a signal 27,000 times as small 
as the previous experiment! 
5.3.1 Response to MCF7 (HER2−) & SKBR3 (HER2+) Cell Lines 
We assign one chip per cell line so the experiment can proceed on the same 
measurement platform with the two chips alternating in a pipeline stream. The probe for 
HER2 was immobilized on both chips at a concentration of 1 mM in a volume of 5 µL. 
After overnight incubation, the chip was rinsed with TGB gently, then mounted on a chip 
carrier, wirebonded, and attached to reservoir tubes. The adhesive used to attach the 
reservoirs was allowed to cure overnight. 
The next morning, we ran a few baseline scans to establish stability. Then we 
removed the excess measurement buffer and applied 25 µL of total RNA at the stock 
concentration of 420 ng/µL in RNase-free water. This concentration is nearly an order of 
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magnitude higher than what we used when probing for total mRNA. We chose to use the 
highest concentration available to increase the chances of seeing a signal from HER2 
mRNA, which, at best, exists at levels less than 40 parts per million (ppm) relative to 
total mRNA. Hybridization was performed through incubation at room temperature for 
approximately one hour, after which the chips were rinsed several times with TGB. 
Finally, three post-hybridization scans were measured.  
A windowed portion of the scan data is shown in Figure 68. The hybridization 
was performed between scan 1 and scan 2: 18 mV for MCF7 and 48 mV for SKBR3. 
Scans 3 and 4 were taken to gauge system stability. MCF7 chip experiences a large 
negative shift (−115 mV from scan 2 to 3), followed by a smaller settling shift. The 
SKBR3 chip also settles but the shifts are within the drift signal of −20 to −30 mV/scan. 
The large negative settling shift of MCF7 may be due to rapid dehybridization of 
RNA, which is notoriously chemically unstable. Another possibility is instability in the 
  
 
Figure 68. Threshold shifts (left) and running total (right) probing for HER2 mRNA in dose of 
420 ng/µL total RNA from MCF7 (blue) and SKBR3 (red). Stability was established with 
multiple scans prior to the four scans shown. Scan 1 was taken before hybridization. After 












































transistors (corrosion of oxide and metal wires). The large difference in chip stability is 
reason to incorporate blank measurements into the experimental protocol. 
The signal due to HER2 is the increase in threshold from scan 1 to scan 2, which 
is summarized in Figure 69. The small response to MCF7 and large response to SKBR3 
are consistent with the overexpression of HER2 mRNA only in SKBR3. However, it is 
also possible that total mRNA from SKBR3 happened to be expressed or extracted at a 
higher level than from MCF7. Thus, we need a basis on which to normalize the HER2 
signal. 
Although the hybridization buffer for the first mRNA detection experiment was 
TGB, in this case, it was simply DI water. This is because we wanted to use the highest 
concentration of RNA available (the stock). The absence of a proper buffer in molecular 
biology is expected to significantly affect hybridization. Furthermore, the switch from 
  
Figure 69. (left) Biosensor response probing for HER2 from total RNA extracted from two 
breast cancer cell lines: SKBR3, which over-expresses HER2, and MCF7, which expresses 
HER2 at normal levels. RNA was incubated on each chip at a concentration of 420 ng/µL total 
RNA. A different chip was used for each cell line. (right) HER2 expression in SKBR3 as 
measured by quantitative real-time PCR (arbitrary units) was 40 times that of MCF7. We have 


























TGB during measurement to DI during hybridization and back to TGB following 
hybridization could also elicit a response from the biosensor. This response must be 
accounted for by performing hybridization with samples consisting of only DI water. 
A comparison of the amounts of RNA and measured signals in this experiment 
with those from the previous experiment can be made from Table 9. We increased the 
dose of total RNA over one order of magnitude since the last experiment. However, the 
mass and concentration of mRNA targeted in this experiment is more than three orders of 
magnitude lower in concentration than in the previous experiment. Yet we were able to 
measure significant signals and match them to the correct cell line. It is remarkable that 
we were able to measure any signal whatsoever! 
On the following day, we tested the two chips in response to a blank hybridization 
in TGB, followed by a blank in DI water (Figure 70). The blank response of M0 was 
−4 mV for TGB and +4 mV for DI. The blank response of S0 was 25 mV for TGB and 
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33 mV for DI. In both cases, the DI response is nearly 10 mV greater than the preceding 
TGB response. The general response of M0 over the 7 scans is a gradual decrease, while 
the response of S0 seems to decrease initially but recover somewhat.  
The signals of these two chips due to blank incubations with TGB and DI are 
summarized in Figure 71. The fact that these two chips had such very different blank 
responses even under the same buffer highlights the need to incorporate regular blanks 




Figure 70. Threshold shifts (left) and running total (right) for biosensors M0 (blue) and S0 (red) 
used previously with MCF7 and SKBR3, in experiment to characterize dependence of blank 

























































5.3.2 Dose Response to SKBR3 with Blanking 
Our next goal was to produce a dose-response curve for HER2 expression in 
SKBR3, while including blanks and using the same buffer throughout experiment. As in 
Section 5.2.1, the result we are looking for is a simple plot that shows an increasing 
response to increasing concentration of total RNA. In planning this experiment, we 
needed to decide what range of concentration to use such that a linear or somewhat linear 
response will be measured. If the concentration range is too low, the plot will likely 
contain only noise and no discernable signal. If the range is too high, the plot may be a 
flat-line saturation response.  
For the highest concentration, we used the stock solution of 400 ng/µL total RNA 
in TGB. While confident that we would detect a signal from the stock concentration, and 
that we probably would detect a signal one decade lower, we were unsure about 
measuring anything from two decades lower (4 ng/µL). Since the lowest dose was 
expected to produce the same response as a blank, it provided extra confirmation of the 
 
Figure 71. Signals due to blank incubations in TGB and DI water for chips M0 (blue) and S0 
(red). In both cases, the DI response is nearly 10 mV higher than the previous TGB response. 
This result highlights the need to incorporate blanks into the overall experimental scheme and 























chip stability. Hybridization was performed in a volume of 25 µL of TGB for 1.5 hours at 
room temperature. We planned to interleave blank hybridizations of only 45 minutes 
between regular hybridizations. In actuality, one blank was skipped between the two 
highest doses due to time constraints.  
As can be seen in Figure 72, increasing shifts of 0 mV, 50 mV, and 106 mV were 
produced from the sequentially decade increases in dose. Also, negligible blank 
responses were achieved throughout the experiment, although the threshold dropped 
rapidly near the end of experiment over repeated scans. This may signal chip aging, as 
there were no such drops in the beginning of experiment. 
The dose-response due to HER2 is plotted in Figure 73. No blank subtraction or 
background subtraction was needed since the blanks were negligible. The overall dose-
response relationship appears to be a logarithmic function of concentration, with a slope 
of about 50 mV/decade.  
 
Figure 72. (left) VTH shifts and (right) VTH running total probing for HER2 in three increasing 
concentrations of SKBR3 total RNA: 4, 40, and 400 ng/µL (D1, D2, D3). It is immediately 
obvious that the trend of increasing shifts from 0 mV, to 50 mV, and finally 106 mV are an 
increasing function of dose. Negligible blank shifts (B) were produced throughout the 

























































The mass, concentrations, and signals of HER2 mRNA in the present and 
previous experiments are listed in Table 10. This time the signal at highest concentration 
of HER2 was 106 mV. The signal at the same concentration was about 50 mV in the last 
experiment. Accounting for the significant blank response to DI water of 25 mV, the 
adjusted signal was 23 mV. In other words, the response this time is 4.6 times as much as 
last time. This may be due to the poor hybridization conditions provided by DI water, 
such as extremely low ionic shielding and acidic pH due to carbon dioxide absorption. 
 
Figure 73. Dose-response curve probing for HER2 in SKBR3 cells. The overall relationship is 
logarithmic function of concentration, with a slope of about 50 mV/decade.  
Table 10. Mass, concentrations, and signals of HER2 mRNA in previous experiment (in DI) and 
this experiment (in TGB).  
Cell line 
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This is the first time that we had access to RNA that was eluted in top-gate buffer, 
which is important in reducing the blank response and providing a proper environment 
for hybridization. We were able to produce a consistent dose-response curve even 
without detailed optimization. However, a major improvement will be made. Increasing 
hybridization temperature to 55 °C will improve the specificity of nucleic acid base-
pairing and lead to less non-specific binding.  
5.3.3 Dose Response to SKBR3 at Elevated Hybridization Temperature 
We next seek to produce another dose-response curve for HER2 in SKBR3, with 
the main improvement of an elevated hybridization temperature for better specificity. As 
detailed in Chapter 3, Luminex experiments showed that elevated hybridization 
temperature was required to achieve discrimination against single-base pair mismatches 
in synthetic targets.  This is reason to suspect that our signals at lower temperatures 
overestimate the true amount of specific target capture.  
We usually take a set of three scans whenever the chip is measured on the 
multiplexer platform following any treatment. To save time, we reduced the scans to two 
per set. Since the third of three scans typically did not provide any important data other 
than chip aging, we expected no significant consequence. 
Hybridizations were performed at a temperature of 55 °C for 90 minutes. Blanks 
were interleaved with hybridizations and shortened to 50 minutes. We applied the same 
dose concentrations as we used in the room temperature dose response. 
As shown in Figure 74, an increasing dose-response is seen among the two 
highest doses, whereas the preceding blanks are insignificant. However, the first blank 
(B1) was at the same level as doses D1 and D2. We compensate for the blank shifts by 
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computing the net signal as the given dose signal less the average of the “shouldering” 
blanks. In other words, the compensated dose signal Ck = Dk – (Bk+Bk+1)/2, where Dk is 
the original signal number k, Bk is the previous blank and Bk+1 is the following blank. In 
the case of D3, where there is no following blank, B4 is taken as equal to B3. 
The adjusted dose-response due to HER2, plotted in Figure 75, and is steadily 
increasing with increasing concentration but appears to saturate across the two higher 
concentrations. As a consequence, we will conduct future experiments in a concentration 
range less than 400 ng/µL. 
 
Figure 74. (left) VTH shifts probing for HER2 in SKBR3 at doses of 4, 40, and 400 ng/µL (D1, 
D2, D3). It is immediately obvious that highest dose produced the highest response. With the 
exception of the first blank (B1), the blank shifts (B2, B3) were negative and of similar 






























5.4 Determination of HER2 Overexpression in Cancer Cells 
Our final goal in this project was to use the CNTFET biosensors to determine the 
over-expression of HER2 mRNA in real cancer cells. If so, this could pave the way for 
using the biosensors to determine HER2 status alongside or even competing with FISH, 
IHC, and RT-PCR. 
5.4.1 Methods 
Our colleagues at NCI had already adopted a methodology to determine over-
expression of HER2 relative to a “housekeeping gene” called GAPDH, which is 
expressed at a normal level in both the SKBR3 and MCF7 cell lines. Sagara et al.77 
produced HER2 statuses via real-time PCR that were statistically significantly correlated 
with gene copy amplification as determined by FISH. Their method was to calculate the 
HER2/GAPDH ratio, which is nearly 3.74 for SKBR3, but only 0.13 for MCF7.  
 
Figure 75. Dose-response curve probing for HER2 in SKBR3 cells, adjusted via shouldering 
blank average subtraction algorithm. Each signal is the computed as the raw shift minus the 
average of preceding and following blanks. The dose-response is increasing fast over the two 
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We adopt the use of the HER2/GAPDH ratio to gauge HER2 over-expression 
using CNTFET biosensors. This required development of PNA probes for GAPDH, 
which was also done with our chemist at NCI. Table 11 shows the exact probe sequences 
that we used to target HER2 and GAPDH. 
Since we had no prior experience working with the GAPDH probe, we did not 
know what concentrations of total RNA to use to achieve the best results in terms of the 
final HER2/GAPDH ratio. We ended up choosing two concentration ranges: low and 
high. Our two previous HER2-only dose-response curves were taken at concentrations of 
5, 50, and 500 ng/µL. We chose to limit the lowest concentration to 50 ng/µL because 
5 ng/µL produced such low HER2 signals from SKBR3 (HER2+) that no signal could be 
expected for HER2 or GAPDH in MCF7 (HER2−). We also tempered the highest 
concentration from 500 ng/µL down to 250 ng/µL to avoid saturating the HER2 probe 
and consuming too much RNA supply. 
To increase experimental throughput and reduce chip consumption, we developed 
the means to section the chip into two separate parts via a small thin-walled 
polypropylene tube (Figure 76). This allowed the immobilization of two different probes 
on a single chip. The probe was typically immobilized in the small reservoir at a 
concentration of 1 mM in 5 µL DI, and in the large reservoir at a concentration of 
Table 11. Names and sequences of 16-mer anti-sense PNA probes for HER2 and GAPDH 
developed at NCI. The probe attachment was achieved via an thiol (SH) group at the 5’ end.  
Name Sequence 
HER2 Probe 5’-/SH/-ACT GGA CCC TAG AGT C-3’ 




0.86 mM in 5.8 µL DI. The transistor measurement scheme was modified to alternate 
between the top and bottom halves. 
Twelve different chips were consumed for a series of experiments spanning four 
months. All the experiments were performed at the NCI laboratory. The hybridization 
incubations were performed at 55 °C for 90 minutes. We incorporated the practice of 
denaturing and snap cooling the RNA to increase hybridization efficiency. The RNA was 
denatured by heating to 95 °C for one minute, then immediately snap-cooling it in ice-
water. This lessens the secondary structure of the RNA, allowing for better hybridization 
to the probe. 
5.4.2 Aggregate Results for MCF7 & SKBR3 
Figure 77 plots the dose-response curves based on adjusted data from a series of 
experiments done over nine different chips. An adjusted signal is generally the raw 
threshold shift minus the average of the shouldering blanks, as explained before. 
However, there are cases in which this method is not appropriate. Blanking can cause a 
 
Figure 76. Biosensor with two reservoirs attached: a smaller tube within a larger tube creating 
two isolated liquid sections, allowing immobilization of probes for HER2 and GAPDH on 






negative shift due to the dehybridization of loosely bound RNA, or can cause large shifts 
due to chip instability. In this case, the data point is either invalid or the shoulder method 
is reverted. 
Figure 78 contains the dose-response curves based on validated, adjusted signals. 
Careful judgment was used in determining when hybridization signals and blank 
responses were invalid due to chip or RNA instability. Negative or near-zero adjusted 
signals were deemed invalid, as were signals considered too high due to chip instability. 
Also, in SKBR3, the two data points at the highest concentration were removed due to 
saturation of the probe from experiments at lower concentrations. This data has been 
condensed into Figure 79, where the data are lumped into low and high concentrations. 
  
Figure 77. Adjusted signals (without filtering) probing for HER2 (red) and GAPDH (blue) in 
total RNA from MCF7 (left) and SKBR3 (right). Composite data from four chips on MCF7 and 







































Figure 78.  Validated adjusted signals probing for HER2 (red) and GAPDH (blue) in total RNA 
from MCF7 (left) and SKBR3 (right). The dotted lines are an aid to the eye. (left) Linear-fit dose 
response to GAPDH is higher than that of HER2. GAPDH content is about 8 times that of HER2 
in MCF7. Composite data from four chips. (right) Linear-fit dose response to HER2 is slightly 
higher than that of GAPDH. HER2 is overexpressed about 4 times as much as GAPDH. 
Optimization is needed to reproduce the contrast between MCF7 and SKBR3 that RT-PCR was 
able to achieve. Composite data from five chips. 
 
Figure 79. Condensed dose-response signals for MCF7 (left) and SKBR3 (right). GAPDH level 










































































5.4.3 Calculation of HER2/GAPDH Ratios 
To determine HER2 status, we calculated the HER2/GAPDH ratio for MCF7 and 
SKBR3 (Table 12 and Table 13). As in Figure 79, the data was grouped into low and 
high concentrations. For MCF7, we calculated HER2/GAPDH ratios of 0.47 and 0.32 and 
the low and high concentrations, respectively. For SKBR3, we obtained HER2/GAPDH 
ratios of 1.35 and 1.12 at the low and high concentrations, respectively. On the average, 
we arrive at HER2/GAPDH ratios of 0.4 and 1.24 for MCF7 and SKBR3, respectively. 
The contrast ratio of SKBR3:MCF7 is 1.24/0.4 = 3.1. 
 
 
Table 12. HER2 and GAPDH responses and ratios for MCF7 cell line. All data with standard 
deviation indicated are for 2 samples. Large uncertainty in ratio at the higher concentration was 
due to the large variation in the HER2 response. 
Dose HER2 (mV) GAPDH (mV) HER2 / 
GAPDH 
Low 37±33 79±35 0.47±0.46 
High 37±11 114±8 0.32±0.10 
     
Table 13. HER2 and GAPDH responses and ratios for SKBR3 cell line. All data with standard 
deviation indicated are for 2 samples.  
Dose HER2 (mV) GAPDH (mV) HER2 / 
GAPDH 
Low 74±8 55 1.35±0.15 
High 102±23 92±19 1.12±0.34 
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5.4.4 Analysis & Discussion 
The results imply that our system, blindly given an unknown sample random 
chosen from MCF7 or SKBR3, can identify which cell line the sample came from on the 
basis of whether the HER2/GAPDH ratio is greater than unity. This scheme could be 
developed further to establish a threshold rule that works over a larger number of cell 
lines, and would be along the lines of commercializing the system for HER2 detection 
from real patient cell samples.  
We do acknowledge that the experiments need be repeated several more times to 
provide data for a more meaningful statistical analysis such as would be seen in a clinical 
trial. We may also need to optimize the probe immobilization and hybridization protocols 
(buffers, temperatures, etc) to increase sensitivity and improve discrimination between 
HER2 and GAPDH. We admit that our system does not produce the same contrast 
between SKBR3 and MCF7 that was obtained by PCR.77 The SKBR3:MCF7 contrast in 
HER2/GAPDH ratio by PCR is 3.738/0.131 = 28.5, which is nearly ten times the contrast 
produced by our biosensor. 
The relatively low contrast may be a consequence of the fundamental logarithmic 
charge-to-voltage response of the biosensor as shown in Figure 64b. Most of our 
responses (see Figure 78) are in the range of 50 to 125 mV, which is where the 
logarithmic nature dominates. Thus it is not difficult to imagine that many signals that 
otherwise would be larger have been diminished. Low contrast may also be due to a 
common background signal such as non-specific adsorption of RNA onto the gold 
attachment surfaces. This is supported by the y-axis intercept of the interpolated dose 
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responses (Figure 78) at a level in the vicinity of 60 mV. Non-specific adsorption may be 
reduced by blocking residual active gold sites with tRNA or other agent. 
The sensitivity of our biosensor may have actually been enhanced by the 
secondary structure (folding) of RNA, bringing more RNA charge within the Debye 
length. This enhancement cannot be gained in the fluorescence-based Luminex or 
microarray methods, since the folding does not enhance fluorescence. We could also 
increase overall sensitivity to HER2 if we gather more HER2 RNA by immobilizing a 
mixture of probes targeting different parts of the HER2 gene, rather than just a single 
probe sequence targeting only one part of the gene. 
While our experimental platform has much room for improvement, it does avoid 
certain pitfalls of PCR, FISH, and other methods of detection. For example, PCR is 
known to have sequence artifacts and bias.53 As a result of the greater hydrogen bonding 
between G-C vs A-T, sequences have a high G-C content may be over-represented in the 
PCR product. Our colleagues at NCI were not able to successfully use the fluorescence-
bead-based Luminex XMAP to detect RNA. This may have been due to failure to attach 
fluorophores to label the infamously unstable RNA molecule. Though they were able to 
measure increased HER2 in SKBR3 relative to MCF7 via a PCR-based method 
(Taqman®), they did not successfully measure the HER2/GAPDH ratio. 
5.5 Conclusion 
We have demonstrated label-free electronic detection of HER2 mRNA in total 
RNA extracted from real cancer cells. Based on comparison with GAPDH mRNA levels, 
our prototype system distinguished which of two breast cancer cell lines is HER2-
positive and which is HER2-negative. The range of total RNA concentration was from 
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50 ng/µL to 250 ng/µL, corresponding to the range of 50,000 to 500,000 cancer cells. 
This number of cells could easily come from a core biopsy, obviating the need for a 
larger sample via surgery. We believe these achievements set the stage for development 
of a rapid, low-cost HER2 biosensor that could serve to augment or even compete with 




Chapter 6: Future Work & Main Conclusions 
6.1 Future Work 
6.1.1 Improvement of HER2 Selectivity & Sensitivity 
As shown in the previous chapter, we were able to detect a contrast between two 
different breast cancer cell lines based on the relative expression levels of HER2 with 
reference to a housekeeping gene. However, our system did not achieve the same level of 
contrast obtained by Q-RT-PCR. As shown in Chapter 3, the probe was verified to be 
highly selective against two base-pair mismatches. The remaining weakness in our 
probing strategy is the lack of any post-immobilization blocking protocol to prevent non-
specific adsorption onto the metal (Au) gate.  
 
Figure 80. Schematic of (A) HS-ssDNA on Au and (B) both HS-ssDNA and MCH adsorbed on 
gold. The ssDNA probes are attached to the gold surface through a sulfur-gold linkage. Source: 
Herne & Tarlov.74 
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As shown in Figure 80, when gold is exposed to thiolated probe DNA, the probe 
nucleotides will attach through the thiol-gold linkage. As expected, most of the probe 
molecules will be oriented perpendicular to the surface so as to be accessible for 
hybridization. However, Steel et al.65 noted that DNA nucleotides can presumably adsorb 
to gold via multiple amine moieties. Thus some of the probe molecules may lay flat and 
be unavailable for hybridization, causing reduction in the hybridization signal and 
increasing the likelihood of false negatives. Furthermore, some fraction of the target 
molecules may non-specifically adsorb to the CNTFET gate, causing false positives. 
 Unreacted surface sites on gold can be blocked with 6-mercapto-1-hexanol 
(MCH). The benefits are twofold. The MCH rapidly displaces weakly adsorbed probe 
from the substrate, leaving the probes tethered through the thiol end groups. The alcohol 
(OH) end groups of MCH tend to repel nucleic acids and do not allow for non-specific 
adsorption of nucleic acids. Moreover, the use of MCH as a space filler enhances the 
accessibility of the probes for hybridization, allowing nearly complete hybridization 
efficiencies.64,65 
The next improvement in the probing technique is to increase the sensitivity to 
HER2. So far we have only employed a single 16-mer probe sequence for HER2. 
However, the HER2 gene is about 41,000 base pairs long, and our collaborators at NCI 
already selected and fabricated several other probe sequences for HER2. We anticipate 
that mixing multiple HER2 probes on each biosensor would result in the capture of more 
parts of the same gene and yield higher hybridization signals.  
An alternative to seeking higher signals is to reduce the noise interfering with 
small signals. Along these lines, we should attempt to improve the uniformity of the 
 153 
 
transistor characteristics or to come up with a clever scheme to calibrate the individual 
signals despite the transistors’ nonuniformity. 
6.1.2 Single-Walled CNTFET vs. NTNFETs 
Currently our sensors are based on spaghetti-like nanotube mats. Each device may 
have several tubes with different metallic or semiconducting properties in unknown series 
and parallel combinations.  
Star et al.13 saw several advantages to carbon nanotube network field-effect 
transistors (NTNFETs). The random network avoids the challenges of alignment and 
averages out inter-device variations due to chirality and precise geometry. Devices can be 
developed on low-cost flexible polymer substrates by spray deposition, spin-coating, or 
nanotransfer printing.9 
To fully utilize the outstanding electronic properties of the nanotubes, well-
defined CNTFETs could be made out of aligned single-walled nanotubes grown on 
quartz.78 A single-tube CNTFET would be expected to have superior intrinsic sensitivity 
since it is a true nanoscale sensor. However, it is still unclear if this noble venture would 
be worthwhile. Nanotubes exhibit a significant level of 1/f noise12 that is inversely 
proportional to the number of CNTs in the device. A network with a large number of 
SWNTs reduces the 1/f noise by approximately the number of SWNTs raised to the 
(−1.3) power.79 In the overall biosensor system, further study is needed to identify the 
most severe noise sources. If 1/f noise is a significant contributor, then large nanotube 
networks will have a distinct advantage over single-channel devices. 
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6.1.3 System Integration, Expansion, & Commercialization  
Our vision for the future is for a cancer patient to walk into the clinic, provide a 
biopsy sample, and receives her HER2 results in the same visit. We believe this could 
only be accomplished with a highly integrated laboratory-on-a-chip system driven by 
microfluidics. For example, the biopsied tissue sample contains a variety of cell types, 
such as ductal, lobular, lymph, and adipose (fat). The HER2 status should be taken from 
the primary cancer cells. A practical application of microfluidics would be to segregate 
all the different cells in the sample into cancerous and non-cancerous cell types. Then the 
cancer cells could be lysed, possibly with electric field, to aid in chemical extraction of 
the RNA. If for some application, PCR amplification is needed, this could be integrated 
on-chip. Or, a separate stage could separate mRNA from total RNA as a pre-treatment to 
enhance detection of HER2 mRNA. Other benefits of microfluidics include faster 
throughput, reduced reagent consumption, and expansion into series/parallel analysis of 
the same input sample.80 
Another obvious area of future work is the integration of the detection system 
with peripheral circuit blocks for multiplexing, signal conditioning/calibration, and final 
readout. Alternatively portions of the signal processing and final readout/analysis can be 
done on a notebook computer. 
We believe that this work will pave the way for commercialization of a low-cost, 
rapid cancer detection system that would be licensed as a platform for development of 
protocols to detect a variety of other diseases, such as dengue, typhoid, and E. coli. The 
method of detection is so versatile that it only needs the proper probe and accompanying 
protocol to be applied to another new challenge.  
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6.2 Main Conclusions 
We developed a prototype biosensor platform that successfully discriminated 
between a HER2+ cell line and a HER2− cell line. Each biosensor required no more than 
~10 µg of total RNA extracted from no more than ~500,000 cancer cells. This number of 
cells could be obtained in a core biopsy from a living patient, obviating the need for a 
larger sample via surgery. To the best of our knowledge, this system is the first CNTFET-
based system to directly detect unlabelled HER2 mRNA at clinically relevant levels. This 
was facilitated in large part due to the use of electrically neutral peptide nucleic acids 
(PNA), which allow the use of much lower ionic shielding as compared to conventional 
DNA probes. 
Our biosensors are also unique in the use of a gate dielectric and metallic gate 
surface to isolate the carbon nanotube mats from the hybridization reaction. While 
sensitivity is traded for selectivity, the aluminum oxide dielectric virtually eliminates the 
hysteresis caused by water molecules and provides superior resistance against positive 
mobile ion (sodium, potassium) penetration as compared to silicon oxide. The metallic 
gate further helps to prevent ionic contamination and also provides a chemically stable 
surface for probe attachment. 
Future incremental improvements may include (i) reducing the device-to-device 
variation or developing a calibration scheme to overcome this non-uniformity, (ii) 
employing a set of HER2 probes (as opposed to a single HER2 probe sequence) to 
increase the hybridization signal, and (iii) optimizing the surface chemistry to increase 
selectivity. More significant improvements may be oriented at the system level, including 
integration with microfluidics as well as on-chip measurement circuitry. Such a versatile 
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platform could easily be expanded to detect other pathogens & biomarkers through an 
arrangement in which the platform is licensed to companies specializing in assay 
development. We believe that we have lowered the barrier toward commercialization of a 




7.1 Custom Instrumentation & Software 
A custom measurement and analysis system was designed to allow rapid 
acquisition of current-voltage (I–V) curves of an array of field-effect transistors. The 
hardware instrumentation provides the gate and drain voltages and measures the 
respective currents of one CNTFET at a time. The software component consists of a 
Windows program to control the measurement routine and a MATLAB program to 
analyze the collected data. 
7.1.1 Hardware Instrumentation 
As shown in Figure 81, the hardware instrumentation consists of several devices 
 
Figure 81. Instrumentation block diagram. The system is controlled by a notebook PC via USB. 
Two Keithley 2400 SourceMeters provide the drain and gate voltages (VDS, VGS) to the 
CNTFETs, while an analog multiplexer (MUX) selects one transistor at any given time. The PC 
interfaces to the SourceMeters via a USB-GPIB adaptor, and to the analog multiplexer via a 
USB digital I/O module (DT9812). The 64-channel multiplexer is based on two integrated circuit 
32-channel analog multiplexers. 
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controlled by a notebook PC via USB. Two Keithley 2400 SourceMeters provide the 
drain and gate voltages to the CNTFETs, while an analog multiplexer selects one 
transistor at any given time. The PC interfaces to the SourceMeters via a USB 2.0 to 
GPIB (IEEE-488) controller module (488-USB2, ICS Electronics). The PC also 
interfaces with the analog multiplexer via the digital input/output function of a low cost 
USB data acquisition module (DT9812, Data Translation). The 64-channel multiplexer is 
based on two integrated circuit 32-channel analog multiplexers (ADG732BCP, Analog 
Devices). 
Figure 82 shows one of three actual hardware instrumentation setups that we 
deployed at NCI in Gaithersburg, Maryland. The analog multiplexers and the socket for 
the biosensor chip were wired together on a hand-wired prototyping breadboard. The 
biosensor plugs into a socket (3M) in the middle of the measurement platform, and is 
held in place by a custom-machined “U” clamp. A plastic cap attaches to the socket and 
houses the top-gate electrodes. The multiplexer ICs in surface-mount Quad Flat Packages 
(QFP) were hand-soldered to adapter boards (ePBoard) for use in standard “dual in-line 
package” (DIP) sockets on the breadboard, which also contains the connectors for the 
SourceMeter and digital I/O cables. 
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7.1.2 Measurement Control Software  
We wrote custom software to control the batch measurement of transfer 
characteristics of CNTFETs over the entire chip and store the data to disk for further 
analysis. The program is called “BMBatch”, which stands for “Basic Measure Batch”. 
This program originally had a simple text-mode interface but was upgraded to include a 
graphical user interface (GUI) as a courtesy by Michael Dreyer at LPS. 
 
Figure 82. Custom measurement system including (from foreground to background) 
measurement platform, USB digital I/O box, power supplies, and notebook PC. The chip carrier 
plugs into the middle of the measurement platform and is covered by a clear protective cap that 
houses the top gate electrodes. The green printed circuit boards adapt the multiplexers in surface 
mount packages for use in “dual in-line package” (DIP) sockets. The note on green tape says, 
















The BMBatch user interface, shown in Figure 83, includes real-time plots of the 
gate and drain I–V curves, as well as controls for automating batch measurement and 
adjusting critical configuration details. Batch measurement of multiple devices is 
 
Figure 83. Screenshot of BMBatch custom I–V curve measurement software. On the right hand 
side are two plots of I–V curves, one for the gate and one for the drain. The top plot shows the 
gate current (IG–VGS) for diagnostic purposes. The bottom plot is the transfer characteristic (ID–
VGS) recorded for the currently addressed CNTFET. The pane on the left hand side contains 
configuration parameters such as voltage range and number of data points. Other parameters 
such as delay time, measurement time, and current limits are uploaded to the SourceMeters. The 
bottom section contains buttons for starting and stopping the measurement, as well as options for 
batch scanning, such as the working directory (WD), current trial directory name (Tdir), and 
number of repeat scans (3X). Written in C++ using Microsoft Visual Studio 6.0 (1998). 
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accomplished by loading a batch description text file wherein each line specifies the 
multiplexer channel number, device number, and molecular probe. For example, 
“39,d28B-“ indicates channel 39, device 28, probe B. The transfer characteristics will 
then be saved to disk as comma-separated values (CSV) for analysis in MATLAB in a 
directory structure as shown in Figure 84. 
7.1.3 MATLAB Analysis 
After data is acquired via BMBatch, a suite of MATLAB scripts called 
“ShiftVthBatch” plots the transfer characteristics of all transistors stored in all the trial 
directories. As shown in Figure 85, a parabola is fitted to the five lowest data points of 
 
Figure 84. Example directory structure where BMBatch stores acquired data. In analysis, 
ShiftVTHbatch.m traverses these directories. (left) Chip-level directory, including 9 trial 
subdirectories, channel-device specification, and measurement configuration.  (right) Contents of 
one trial directory include a configuration file and a CSV file for each device. 
 162 
 
each curve, which is warranted because when VGS ≈ VTH, the transistor is in the saturation 
regime, and Equation (1) gives: 
 ( )2THGSD VVI −∝  (41) 
The data is fit in a least-squares sense with a second order polynomial using the 
MATLAB function “polyfit”, which returns the coefficients for a parabola of the form: 
𝑦 = 𝑎𝑉𝐺𝑆2 + 𝑏𝑉𝐺𝑆 + 𝑐. The interpolated threshold voltage given by 𝑉𝑇𝐻 =–
𝑏
2𝑎
. Each VTH 
is stored in an array location corresponding to the trial number and device number.  
The threshold shift of one FET at any trial is the increase in threshold from the 
previous trial. As shown in Figure 86, these shifts are plotted as a function of trial 
number. The mean VTH shift for the group of FETs at every trial is computed and plotted. 
The user is given an opportunity to revise the set of transistors that are included in the 
analysis and the revised data is redisplayed. After successive iterations have been 
  
Figure 85. (left) Zoom of region of transfer characteristic used for VTH interpolation. For each 
transistor, a parabola (red) is fitted to a subset (green) of five points from the original data (blue). 
The interpolated threshold voltage (red X) is then stored in an array. (right) Transfer 
characteristics of the same transistor from two consequent trials (1: blue, 2: red). The threshold 

























completed to the satisfaction of the user, the relevant group data (such as mean and 
standard deviation of the shifts versus trial number) are written to an Excel spreadsheet.  
7.2 UHV Iron Evaporation 
Chip throughput was originally slow because only two chips could be loaded in 
parallel on UHV system and pump-down takes about one hour. Throughput was more 
than doubled after we adopted a multi-chip holder developed at LPS (Figure 87). 
        
 
Figure 86. The VTH shifts of three transistors (yellow, red, cyan) as a function of trial number. 
The mean shift (blue) and standard deviation (error bars) characterize the group behavior. From 
this plot, the user can decide which transistors should be excluded from analysis. Once the user 
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Num Trial mean stdev
20 r -52 66
21 r -11 17
22 RNA 124 51
23 r -43 60
24 r -5 13
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7.3 Reservoir Attachment Rig 
 
Figure 87. (left) Original UHV chip holder for one chip only (two holders could be loaded for 
deposition simultaneously). (right) Scaled up UHV chip holder cradling five chips per deposition 
cycle. 
  
Figure 88. Cup attachment rig (courtesy Prof. Gomez).  This setup gives the user 
a microscopic bird’s eye view to precisely position the adhesive-laden reservoir over the 
active area of the chip without bumping into the fragile bond wires.  
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